US20120089138A1 - Gerd treatment apparatus and method - Google Patents
Gerd treatment apparatus and method Download PDFInfo
- Publication number
- US20120089138A1 US20120089138A1 US13/327,105 US201113327105A US2012089138A1 US 20120089138 A1 US20120089138 A1 US 20120089138A1 US 201113327105 A US201113327105 A US 201113327105A US 2012089138 A1 US2012089138 A1 US 2012089138A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- expandable member
- electrode
- energy
- esophageal sphincter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1485—Probes or electrodes therefor having a short rigid shaft for accessing the inner body through natural openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/148—Probes or electrodes therefor having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0475—Tracheal tubes having openings in the tube
- A61M16/0477—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
- A61M16/0481—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids through the cuff wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00106—Sensing or detecting at the treatment site ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22062—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22072—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B2017/4216—Operations on uterus, e.g. endometrium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00023—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00065—Material properties porous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00077—Electrical conductivity high, i.e. electrically conducting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00113—Coatings on the energy applicator with foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00148—Coatings on the energy applicator with metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/0016—Energy applicators arranged in a two- or three dimensional array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00494—Stomach, intestines or bowel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00553—Sphincter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00559—Female reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
- A61B2018/00708—Power or energy switching the power on or off
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00726—Duty cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00738—Depth, e.g. depth of ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00744—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00755—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00761—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00797—Temperature measured by multiple temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00815—Temperature measured by a thermistor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00827—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00869—Phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00886—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00892—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00898—Alarms or notifications created in response to an abnormal condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/0091—Handpieces of the surgical instrument or device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/0091—Handpieces of the surgical instrument or device
- A61B2018/00916—Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00982—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B2018/0231—Characteristics of handpieces or probes
- A61B2018/0262—Characteristics of handpieces or probes using a circulating cryogenic fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
- A61B2018/046—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1273—Generators therefor including multiple generators in one device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/361—Image-producing devices, e.g. surgical cameras
- A61B2090/3614—Image-producing devices, e.g. surgical cameras using optical fibre
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0434—Cuffs
- A61M16/0454—Redundant cuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0434—Cuffs
- A61M16/0454—Redundant cuffs
- A61M16/0459—Redundant cuffs one cuff behind another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1086—Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/12—Shape memory
Definitions
- Gastroesophageal reflux disease is a common gastroesophageal disorder in which the stomach contents are ejected into the lower esophagus due to a dysfunction of the lower esophageal sphincter (LES). These contents are highly acidic and potentially injurious to the esophagus resulting in a number of possible complications of varying medical severity.
- the reported incidence of GERD in the U.S. is as high as 10% of the population (Castell D O; Johnston B T: Gastroesophageal Reflux Disease: Current Strategies For Patient Management. Arch Fam Med, 5(4):221-7; (1996 April)).
- GERD GERD causes adenocarcinoma, or cancer of the esophagus, which is increasing in incidence faster than any other cancer (Reynolds J C: Influence Of Pathophysiology, Severity, And Cost On The Medical Management Of Gastroesophageal Reflux Disease. Am J Health Syst Pharm, 53(22 Suppl 3):S5-12(15 Nov. 1996)).
- Nissen fundoplication involves constructing a new “valve” to support the LES by wrapping the gastric fundus around the lower esophagus.
- abdominal surgery including: postoperative infection, herniation at the operative site, internal hemorrhage and perforation of the esophagus or of the cardia.
- Laparoscopic Nissen fundoplication reported by Dallemagne et al. Surgical Laparoscopy and Endoscopy, Vol. 1, No. 3, (1991), pp. 138-43 and by Hindler et al. Surgical Laparoscopy and Endoscopy, Vol. 2, No. 3, (1992), pp. 265-272, involves essentially the same steps as Nissen fundoplication with the exception that surgical manipulation is performed through a plurality of surgical cannula introduced using trocars inserted at various positions in the abdomen.
- an object of the invention is to provide an apparatus and method for the treatment of GERD.
- Another object of the invention is to provide an apparatus and method to treat GERD using minimally invasive surgical methods such as non-percutaneous methods.
- Yet another object of the invention is to provide an apparatus and method to treat the esophageal sphincters using minimally invasive surgical methods.
- Another object of the invention is to provide an apparatus and method to tighten the LES.
- a further other object of the invention is to provide an apparatus and method to reduce the frequency of spontaneous relaxation and opening of the LES.
- Yet another object of the invention is to provide an apparatus and method to reduce the frequency and severity of gastroesophageal reflux events.
- an apparatus with an expandable member sized to be positionable in a sphincter.
- the energy delivery device is coupled to the expandable member and has a configuration that controllably produces lesions of a sufficient size, number and configuration in a sphincter so as to create a selectable tightening of the sphincter.
- FIG. 1 is an illustrated lateral view of the upper GI tract including the esophagus and lower esophageal sphincter and the positioning of the GERD treatment apparatus of the present invention the lower esophageal sphincter.
- FIG. 2 is a lateral view of the present illustrating apertures in the expandable member.
- FIG. 3 illustrates a lateral view of an embodiment of the invention that includes two expandable members and an electrode coupled to a power source.
- FIG. 4 illustrates a lateral view of a proximal fitting and distal segments of an embodiment of the invention.
- FIG. 5 illustrates a lateral view of the deflection mechanism of the invention.
- FIG. 6A illustrates a lateral view of apertures in the expandable member and conforming member of the invention.
- FIG. 6B illustrates a lateral view of a microporous membrane used in the fabrication of the expandable member and conforming members of the invention.
- FIG. 7 is a lateral view illustrating the use of the deflection mechanism to deflect the expandable member of the present invention.
- FIG. 8 is a lateral view illustrating the use of electrolytic solution to create an enhanced RF electrode.
- FIG. 9A is a lateral view illustrating a radial distribution of electrodes on the expandable member of the invention.
- FIG. 9B is a lateral view illustrating a longitudinal distribution of electrodes on the expandable member of the invention.
- FIG. 9C is a lateral view illustrating a spiral distribution of electrodes on the expandable member of the invention.
- FIG. 10 is a lateral view illustrating the placement of electrodes on the distal segment of an embodiment the invention.
- FIG. 11 is a lateral view illustrating the placement of needle electrodes on the expandable member of an embodiment the invention.
- FIG. 12 is a lateral view illustrating the deployment of needle electrodes into the smooth muscle of the LES.
- FIG. 13 is a lateral view illustrating the position of needle electrodes in the distal segment of the expandable member.
- FIG. 14 is a flow chart illustrating the GERD treatment method of the current invention.
- FIG. 15A-C are lateral views which illustrate a technique for proper positioning of the GERD treatment apparatus in the LES.
- FIG. 16 is a lateral view of sphincter smooth muscle tissue illustrating electromagnetic foci and pathways for the origination and conduction of aberrant electrical signals in the smooth muscle of the lower esophageal sphincter.
- FIG. 17 is a lateral view illustrating a zone of electrodes of the current invention that comprises a flexible circuit that facilitates contact with the lower esophageal sphincter.
- FIG. 18 is a lateral view of the esophageal wall illustrating the infiltration of tissue healing cells into a lesion in the smooth tissue of a esophageal sphincter following treatment with the GERD treatment apparatus of the present invention.
- FIGS. 19 a and 19 b are views similar to that of FIG. 18 illustrating shrinkage of the lesion site caused by cell infiltration.
- FIG. 20 is a lateral view of the esophageal wall illustrating the preferred placement of lesions in the smooth muscle layer of a esophageal sphincter.
- FIG. 21 is a lateral view illustrating the creation of zones of decreased porosity by sealed conforming members of an embodiment of the present invention.
- FIG. 22 is a lateral view illustrating the ultrasound transducer, ultrasound lens and ultrasound power source of an embodiment of the present invention.
- FIGS. 23A-D are lateral views of the esophageal wall illustrating various patterns of lesions created by the apparatus of the present invention.
- FIG. 24 is a lateral view of the esophageal wall illustrating the delivery of cooling fluid to the electrode-tissue interface and the creation of cooling zones.
- FIG. 25 depicts the flow path, fluid connections and control unit employed to deliver fluid to the electrode-tissue interface and electrodes.
- FIG. 26 is a lateral view illustrating the placement of cooling apertures adjacent to electrodes in the expandable member.
- FIG. 27 depicts the flow path, fluid connections and control unit employed to deliver fluid to the RF electrodes.
- FIG. 28 is an enlarged lateral view illustrating the placement of sensors on the expandable member.
- FIG. 29 depicts a block diagram of the feed back control system that can be used with the GERD treatment apparatus as shown in FIG. 3 .
- FIG. 30 depicts a block diagram of an analog amplifier, analog multiplexer and microprocessor used with the feedback control system of FIG. 29 .
- FIG. 31 depicts a block diagram of the operations performed in the feedback control system depicted in FIG. 29 .
- one embodiment of GERD treatment apparatus 10 that is used to deliver energy to a treatment site 12 to produce lesions 14 in the LES includes a first expandable member 16 with an interior surface 18 and an exterior surface 20 .
- First expandable member 16 which can also be an energy delivery device support member, is configured to receive an expansion medium 22 that inflates first expandable member 16 from a compacted, non-deployed state to a deployed state.
- Exterior surface 20 includes a plurality of apertures 24 . Upon the application of sufficient pressure, first expandable member 16 weeps expansion medium 22 from interior surface 18 .
- expandable member 16 While expandable member 16 , with a single interior surface 18 , is preferred, it will be appreciated that expandable member 16 can be made of different compositions or materials, with one or more open or closed cells or chambers. The plurality of such cells or chambers can be compressed or configured in a small diameter for insertion, and are then expanded after insertion to establish the desired electrical contact with the targeted surface of the esophagus.
- Expansion medium 22 may be a gas, fluid or the like.
- the expansion medium 22 can be an electrolytic solution.
- expansion medium 22 can also be a contrast solution to facilitate imaging of the procedure by fluoroscopy or ultrasonography.
- GERD treatment apparatus 10 can include visualization capability including, but not limited to a viewing scope, ultrasound, an expanded eyepiece, fiber optics (including illumination and imaging fibers), video imaging, a light source and the like.
- a second expandable member 26 can be positioned at least partially adjacent to first expandable member 16 . Second expandable member 26 receives at least a portion of the expansion medium 22 from interior surface 18 .
- An electromagnetic energy delivery device 28 is coupled to one of the first or second expandable members 16 and 26 , respectively, and configured to be coupled to a power source 30 .
- First and second expandable members 16 and 26 are sized to be expanded to sufficiently dilate the esophagus such that all or a portion of the interior of the lower esophageal sphincter can be accessible to the energy delivery device 28 .
- Expandable members 16 or 26 can dilate the esophageal sphincter in a range of 5-40 mms. It will be appreciated that other devices capable of being in confined non-deployed states, during their introduction into the esophagus and thereafter expanded to deployed states at or near the LES, can be utilized. Such devices include, but are not limited to, basket-shaped devices made of superelastic metals such as nitinol.
- an extension member 32 with a distal segment 34 is configured to be coupled to first and/or second expandable members 16 and 26 .
- extension member 32 is rod-like and can be malleable, flexible, articulated and steerable.
- extension member 32 can contain optics, fluid and gas paths, sensor and electronic cabling.
- extension member 32 can be a coil-reinforced multilumen catheter, as is well known to those skilled in the art.
- Extension member 32 has sufficient length to position the first and second expandable members in the LES and/or stomach using a trans-oral approach. Typical lengths include, but are not limited to, a range of 40-180 cms.
- extension member 32 runs through the center of expandable member 16 and/or 26 and distal segment 34 that extends distally beyond the most distal expandable member. Extension member 32 may be attached to a movable proximal fitting 36 used to control deflection of expandable members 16 or 26 , as is more fully explained herein.
- expandable members 16 and 26 may be initially rolled or folded around extension member 32 .
- Expandable members 16 and 26 can be attached to a deflection mechanism 38 , which imparts movement of first and second expandable members 16 and 26 when positioned at the LES.
- the deflection mechanism can be a pull wire attached to extension member or first expandable member 16 and to a movable proximal fitting 36 , as is well known to those skilled in the art.
- Formed spring wires can be included in first expandable member 16 to assist in opening it to the deployed position.
- Optionally positioned proximal fitting contains a variety of actuators which provide a physician control of GERD treatment apparatus 10 , as more fully described hereafter.
- the actuators can be rocker switches, slider switches and the like, as are well known to those skilled in the art. At least portions of GERD treatment apparatus 10 may be sufficiently radiopaque in order to be visible under fluoroscopy and/or sufficiently echogenic to be visible under ultrasonography.
- First expandable member 16 is made of a material that can be an insulator.
- an insulator is a barrier to thermal or electrical energy flow.
- expandable member 16 is substantially surrounded by a conforming member 40 which is also called a fluid conduit.
- Conforming member 40 receives electrolytic solution from first expandable member 16 , heated or not heated, through a plurality of apertures 24 formed in first expandable member 16 , and passes it to conforming member 40 .
- first expandable member 16 is made of a microporous material 42 that does not include distinct apertures.
- conforming member 40 is made of a material that permits controlled delivery of the electrolytic solution to the treatment site 12 through one or more apertures 24 .
- conforming member 40 can be made of microporous material 42 that does not include distinct apertures.
- Extension member 32 with first and second expandable members, or alternatively with a single expandable member, is introduced into the esophagus directly, shown in FIG. 1 , or through the use of another introducer such as an endoscope (not shown), as is more fully described hereafter with first and second expandable members 16 and 26 in non-deployed configurations.
- first expandable member 16 can be deflected from side to side to facilitate maneuvering through the esophagus and positioning in the LES. This movement can be imparted by deflection mechanism 38 .
- a variety of energy sources can be coupled to the porous membrane including, (i) an RF source coupled to an RF electrode, (ii) a coherent source of light coupled to an optical fiber, (iii) an incoherent light source coupled to an optical fiber, (iv) a heated fluid coupled to a catheter with an open channel configured to receive the heated fluid, (v) a heated fluid coupled to a catheter with an open channel configured to receive the heated fluid, (vi) a cooled fluid coupled to a catheter with a closed channel configured to receive the cooled fluid, (vii) a cooled fluid coupled to a catheter with an open channel configured to receive the cooled fluid, (viii) a cryogenic fluid, (ix) a resistive heating source, (x) a microwave source providing energy from 915 MHz to 2.45 GHz and coupled to a microwave antenna, (xi) an ultrasound power source coupled to an ultrasound emitter, wherein the ultrasound power source produces energy in the range of 300 KHZ to 3 GHz or (xii) a microwave source.
- the energy source utilized is an RF source and electromagnetic energy delivery device 28 is a single or a plurality of RF electrodes 44 , also described as electrodes 44 .
- electromagnetic energy delivery device 28 is a single or a plurality of RF electrodes 44 , also described as electrodes 44 .
- all of the other mentioned energy sources are equally applicable to GERD treatment apparatus 10 .
- RF electrode 44 may operated in either bipolar or monopolar mode with a ground pad electrode.
- a monopolar mode of delivering RF energy a single electrode 44 is used in combination with an indifferent electrode patch that is applied to the body to form the other contact and complete an electrical circuit. Bipolar operation is possible when two or more electrodes 44 are used. Multiple electrodes 44 may be used.
- electrolytic solution serves as an enhanced RF electrode 44 ′ when coupled with an RF electrode 44 (refer to FIG. 8 ).
- power source 30 which will now be referred to as a RF energy source 30 , may have multiple channels, delivering separately modulated power to each electrode 44 . This reduces preferential heating that occurs when more energy is delivered to a zone of greater conductivity and less heating occurs around electrodes 44 which are placed into less conductive tissue. If the tissue hydration or the blood infusion in the tissue is uniform, a single channel RF energy source 30 may be used to provide power for generation of lesions 14 relatively uniform in size.
- cell injury will include all cellular effects resulting from the delivery of energy from the electrode 44 up to and including cell necrosis.
- Cell injury can be accomplished as a relatively simple medical procedure with local anesthesia. In one embodiment, cell injury proceeds to a depth of approximately 1-4 mms from the surface of the mucosal layer.
- electrodes 44 can cover all or a portion of expandable members 16 or 26 and/or conforming member 40 . Also, electrodes 44 may be distributed in a variety of patterns along an exterior or interior surface of either expandable member 16 or 26 or conforming member 40 , in order to produce a desired placement and pattern of lesions 14 . Typical electrode distribution patterns include, but are not limited, to a radial distribution 46 (refer to FIG. 9A ) or a longitudinal distribution 48 (refer to FIG. 9B ). It will be appreciated that other patterns and geometries for electrode placement, such as a spiral distribution 50 (refer to FIG. 9C ) may also be suitable. In one embodiment, electrode 44 is positioned on distal segment 34 of extension member 32 (refer to FIG. 10 ). These electrodes may be cooled as described hereafter. Additionally, distal segment 34 may include apertures 24 for delivery of cooling and electrolytic solution as described hereafter.
- Electrodes 44 can have a variety of shapes and sizes. Possible shapes include but are not limited to circular, rectangular, conical and pyramoidal. Electrode surfaces can be smooth or textured and concave or convex. Surface areas can range from 0.1 mm2 to 200 mm2. It will be appreciated that other geometries and surface areas may be equally suitable. In one embodiment, electrodes 44 can be in the shape of needles and of sufficient sharpness and length to penetrate into the smooth muscle of the esophageal wall. In this case, needle electrodes 52 are attached to expandable member 16 or 26 which is located inside conforming member 40 (refer to FIG. 11 ). During introduction of the GERD treatment apparatus 10 into the esophagus, needle electrodes 52 remain retracted inside conforming member 40 .
- needle electrodes 52 are deployed by expansion of expandable member 16 or 26 , resulting in protrusion of needle electrodes 52 through needle apertures 54 in conforming member 40 and into the smooth muscle tissue of the treatment site 12 (refer to FIG. 12 ).
- distal segment 34 may also contain needle apertures 54 for protrusion of needle electrodes 52 into the smooth muscle of the esophageal wall.
- needle electrodes 52 are coupled to an insulated guide wire 56 (known to those skilled in the art) which is advanced through a guide wire lumen 58 in extension member 32 .
- FIG. 14 is a flow chart illustrating one embodiment of the operation of GERD treatment apparatus 10 .
- GERD treatment apparatus 10 is first introduced into the esophagus under local anesthesia.
- GERD treatment apparatus 10 can be introduced into the esophagus by itself or through a lumen in an endoscope, such as disclosed in U.S. Pat. Nos. 5,448,990 and 5,275,608, incorporated herein by reference, or similar esophageal access device known to those skilled in the art.
- Expandable member 16 or 26 is expanded with the introduction of a fluid or gaseous expansion medium 22 , such as an electrolytic solution, or a combination of both.
- esophageal dilation and subsequent LES fold effacement can be accomplished by insufflation of the esophagus (a known technique) using gas introduced into the esophagus through a channel in the GERD treatment device, or an endoscope or similar esophageal access device as described above.
- insufflation of the esophagus a known technique
- gas introduced into the esophagus through a channel in the GERD treatment device, or an endoscope or similar esophageal access device as described above.
- electrolytic solution is introduced into expandable member 16 or 26 , causing it to become distended and be self-retained in the esophagus.
- Expandable member 16 or 26 can also be expanded mechanically through the use of formed spring wires (not shown) used alone or in combination with a fluid.
- Electrolytic solution in expandable member 16 may be heated to a temperature, which can be modified and adjusted as necessary.
- electrolytic solution can be heated and maintained at a temperature between about 65-90° C. It can be initially introduced into first expandable member 16 at the higher temperature, or it can be heated to the higher temperature in first expandable member 16 .
- By providing a heated electrolytic solution there is a reduction in the amount of time needed to complete a satisfactory degree of tissue injury of targeted cells.
- the diagnostic phase then begins. This is achieved through a variety of diagnostic methods, including, but not limited to, the following: (I) visualization of the interior surface of the esophagus via an endoscope or other viewing apparatus inserted into the esophagus, (ii) visualization of the interior morphology of the esophageal wall using ultrasonography to establish a baseline for the tissue to be treated, (iii) impedance measurement to determine the electrical conductivity between the esophageal mucosal layers and GERD treatment apparatus 10 and (iv) measurement and surface mapping of the electropotential of the LES during varying time periods which may include such events as depolarization, contraction and repolarization of LES smooth muscle tissue. This latter technique is done to determine specific sites in the LES to be treated which are acting as foci 60 or pathways 62 for abnormal or inappropriate polarization and relaxation of the smooth muscle of the LES (Refer to FIG. 16 ).
- GERD treatment apparatus 10 In the treatment phase, the delivery of energy of the targeted site can be conducted under feedback control, manually or a combination of both.
- Feedback control enables GERD treatment apparatus 10 to be positioned and retained in the esophagus during treatment with minimal attention by the physician.
- GERD treatment apparatus 10 When positioned at the LES, GERD treatment apparatus 10 provides a relatively even flow of heated electrolytic solution to facilitate the cell injury process.
- GERD treatment apparatus 10 also may have a plurality of electrodes 44 contained in zones that effectively create a flexible circuit 64 which in turn, facilitates contact of the electrode 44 with all or a portion of the interior surface areas of the LES. Electrodes 44 can be multiplexed in order to treat the targeted site or only a portion thereof.
- Feedback can be included and is achieved by, (I) visualization, (ii) impedance measurement, (iii) ultrasonography, (iv) temperature measurement; and, (v) sphincter contractile force measurement via manometry.
- the feedback mechanism permits the selected on-off switching of different electrodes 44 of the flexible circuit 64 in a desired pattern, which can be sequential from one electrode 44 to an adjacent electrode 44 , or can jump around between non-adjacent electrodes 44 .
- Individual electrodes 44 are multiplexed and volumetrically controlled by a controller.
- the area and magnitude of cell injury in the LES can vary. However, it is desirable to deliver sufficient energy to the targeted treatment site 12 to be able to achieve tissue temperatures in the range of 55-95° C. and produce lesions 14 at depths ranging from 1-4 mm from the interior surface of the LES. Typical energies delivered to the esophageal wall include, but are not limited to, a range between 100 and 50,000 joules per electrode 44 . It is also desirable to deliver sufficient energy such that the resulting lesions 14 have a sufficient magnitude and area of cell injury to cause an infiltration of lesion 14 by fibroblasts 66 , myofibroblasts 68 , macrophages 70 and other cells involved in the tissue healing process (refer to FIG. 18 ). As shown in FIGS.
- these cells cause a contraction of tissue around lesion 14 , decreasing its volume and, or altering the biomechanical properties at lesion 14 so as to result in a tightening of LES. These changes are reflected in transformed lesion 14 ′ shown in 19 B.
- the diameter of lesions 14 can vary between 0.1 to 4 mm. It is preferable that lesions 14 are less than 4 mm in diameter in order to reduce the risk of thermal damage to the mucosal layer.
- a 2 mm diameter lesion 14 centered in the wall of the smooth muscle provides a 1 mm buffer zone to prevent damage to the mucosa, submucosa and adventia, while still allowing for cell infiltration and subsequent tightening on approximately 50% of the thickness of the wall of the smooth muscle (refer to FIG. 20 ).
- GERD treatment apparatus 10 conforms tightly with the interior of the esophagus so that all, or nearly all, of the interior circumference of a desired segment of the LES is in contact with a surface of conforming member 40 .
- Conforming member 40 is fitted into the entire LES and expandable member 16 does not have to be moved about the esophagus to complete the treatment.
- GERD treatment apparatus 10 may not entirely fill the esophagus, and GERD treatment apparatus 10 is then moved about the esophagus in order to treat all of the esophagus, or those sections where tightening of the lower esophageal sphincter is desired.
- Conforming member 40 is made of a material that substantially conforms to the surface of the LES and, or other sphincters. This provides better conformity than the mere use of expandable member 16 . As a result, the delivery of treatment energy to the LES is enhanced. Energy delivery may also be enhanced by use of a conducting surface 72 which may cover all, or part of, the exterior of conforming member 40 .
- the surface of conforming member 40 can be made conductive by a variety of means including, but not limited to chemical coating with a conductive material, implantation with conductive ions and application of a conductive film.
- Conforming member 40 can have a thickness in the range of about 0.01 to 2.0 cm.
- Conforming member 40 can be made of a foam type material. Suitable materials include, but are not limited to, knitted polyester, continuous filament polyester, polyester-cellulose, rayon, polyamide, polyurethane, polyethylene, silicone, and the like. Suitable commercial foams include, (i) Opcell, available from Sentinel Products Corp., Hyannis, Massachusetts and (ii) UltraSorb, HT 4201 or HT 4644MD from Wilshire Contamination Control, Carlsbad, Calif. Conforming member 40 has characteristics that make it particularly moldable and formable to irregular surfaces.
- conforming member 40 is made of an open cell foam, or alternatively it can be a thermoplastic film such as polyurethane, low density polyethylene, or it may be a silicone. Additionally, conforming member 40 can be capable of extruding conductive materials from conforming member 40 itself.
- FIG. 21 illustrates that conforming member 40 can be created by sealing two smaller conforming members 74 and 76 together. Smaller conforming members 74 and 76 are sealed together between individual electrodes 44 . This creates a pocket or zone 78 . Zone 78 has a lower porosity for the flow of electrolytic solution than non-zone sections 80 , e.g., all other sections of conforming member 40 which do not include a zone 78 with an associated electrode 44 . The porosity of non-zone sections 80 is greater than the porosity of zones 78 .
- Each ultrasound transducer 84 can include a piezoelectric crystal 86 mounted on a backing material 88 that is in turn attached to expandable members 16 or 26 or conforming member 40 .
- An ultrasound lens 90 fabricated on an electrically insulating material 92 , is mounted over the piezoelectric crystal 86 The piezoelectric crystal 86 is connected by electrical leads to ultrasound power source 82 .
- Each ultrasound transducer 84 transmits ultrasound energy through conforming member 40 or expandable members 16 or 26 into adjacent tissue.
- Ultrasound transducers 84 can be in the form of an imaging probe such as Model 21362, manufactured and sold by Hewlett Packard Company, Palo Alto, Calif. In one embodiment, two ultrasound transducers 84 are positioned on opposite sides of expandable member 16 to create an image depicting the size and position of lesion 14 in the LES.
- lesions 14 are predominantly located in the smooth muscle layer of esophageal wall at the depths ranging from 1 to 4 mms from the interior surface of the sphincter. However, lesions 14 can vary both in number and position within the sphincter wall. It may be desirable to produce a pattern of multiple lesions 14 within the esophageal smooth muscle in order to obtain a selected degree of tightening of the LES. Typical lesion patterns shown in FIGS.
- 23A-C include but are not limited to, (i) a concentric circle of lesions 14 all at fixed depth in the smooth muscle layer evenly spaced along the radial axis of the LES, (ii) a wavy or folded circle of lesions 14 at varying depths in the smooth muscle layer evenly spaced along the radial axis of the LES, (iii) lesions 14 randomly distributed at varying depths in the smooth muscle, but evenly spaced in a radial direction; and, (iv) an eccentric pattern of lesions 14 in one or more radial locations in the smooth muscle wall. Accordingly, the depth of RF and thermal energy penetration in the lower esophageal sphincter is controlled and selectable.
- the selective application of energy to the lower esophageal sphincter may be the even penetration of RF energy to the entire targeted site, a portion of it, or applying different amounts of RF energy to different sites depending on the condition of the sphincter. If desired, the area of cell injury can be substantially the same for every treatment event.
- cooling preserves the mucosal layers and protects or otherwise reduces the degree of cell damage to cooled zone 98 in the vicinity of the lesion 14 .
- This can be accomplished through the use of a cooling fluid 100 that weeps out of the expandable members 16 and 26 or conforming member 40 which is in fluid communication with a continuous lumen 102 in extension member 32 that is, in turn, in fluid communication with fluid reservoir 104 and a control unit 106 , whose operation will be described hereafter that controls the delivery of the fluid (Refer to FIG. 25 ). All or only a portion of electrode 44 may also be cooled.
- Electrode 44 it may also be desirable to cool all or a portion of the electrode 44 .
- the rapid delivery of heat through electrode 44 may result in the build up of charred biological matter on electrode 44 (from contact with tissue and fluids e.g. blood) that impedes the flow of both thermal and electrical energy from electrode 44 to adjacent tissue and causes an electrical impedance rise beyond a cutoff value set on RF energy source 30 .
- a similar situation may result from the desiccation of tissue adjacent to electrode 44 .
- Cooling of the electrode 44 can be accomplished by cooling fluid 100 that weeps out of expandable members 16 and/or 26 and conforming member 40 as described previously.
- expandable member 16 may contain a plurality of cooling apertures 108 adjacent or directed toward electrode 44 to enhance the flow of cooling solution and, or cooling rate of electrode 44 and adjacent tissue (refer to FIG. 26 ).
- electrode may also be cooled via a fluid channel 110 in electrode 44 that is in fluid communication with fluid reservoir 104 and control unit 106 via the continuous lumen 102 in extension member 32 as described previously.
- one or more sensors 112 may be positioned adjacent or on electrode 44 for sensing the temperature of esophageal tissue at treatment site 12 . More specifically, sensors 112 permit accurate determination of the surface temperature of the esophagus at electrode-tissue interface 96 . This information can be used to regulate both the delivery of energy and cooling solution to the interior surface of the esophagus. In various embodiments sensors 112 can be positioned at any position on expandable members 16 and 26 and conforming member 40 . Suitable sensors that may be used for sensor 112 include: thermocouples, fiber optics, resistive wires, thermocouple IR detectors, and the like. Suitable thermocouples for sensor 112 include: T type with copper constantene, J type, E type and K types as are well known those skilled in the art.
- Temperature data from sensors 112 are fed back to control unit 106 and through an algorithm which is stored within a microprocessor memory of control unit 106 . Instructions are sent to an electronically controlled micropump (not shown) to deliver fluid through the fluid lines at the appropriate flow rate and duration to provide control temperature at the electrode-tissue interface 96 (refer to FIG. 28 ).
- the reservoir of control unit 106 may have the ability to control the temperature of the cooling fluid 100 by either cooling the fluid or heating the fluid.
- a fluid reservoir 104 of sufficient size may be used in which the cooling fluid 100 is introduced at a temperature at or near that of the normal body temperature.
- a thermally insulated reservoir 114 adequate control of the tissue temperature may be accomplished without need of refrigeration or heating of the cooling fluid 100 .
- Cooling fluid 100 flow is controlled by control unit 106 or another feedback control system (described herein) to provide temperature control at the electrode-tissue interface 96 .
- a second diagnostic phase may be included after the treatment is completed. This provides an indication of lower esophageal tightening treatment success, and whether or not a second phase of treatment, to all or only a portion of the esophagus, now or at some later time, should be conducted.
- the second diagnostic phase is accomplished through, (I) visualization, (ii) measuring impedance, (iii) ultrasonography or (iv) temperature measurement, (v) measurement of LES tension and contractile force via manometry.
- GERD treatment apparatus 10 is coupled to an open or closed loop feedback system.
- an open or closed loop feedback system couples sensor 346 to energy source 392 .
- RF electrode 314 is one or more RF electrodes 314 .
- the temperature of the tissue, or of RF electrode 314 is monitored, and the output power of energy source 392 adjusted accordingly.
- the physician can, if desired, override the closed or open loop system.
- a microprocessor can be included and incorporated in the closed or open loop system to switch power on and off, as well as modulate the power.
- the closed loop system utilizes a microprocessor 394 to serve as a controller, monitor the temperature, adjust the RF power, analyze at the result, refeed the result, and then modulate the power.
- a tissue adjacent to RF electrode 314 can be maintained at a desired temperature for a selected period of time without impeding out.
- Each RF electrode 314 is connected to resources which generate an independent output. The output maintains a selected energy at RF electrode 314 for a selected length of time.
- a control signal is generated by controller 404 that is proportional to the difference between an actual measured value, and a desired value.
- the control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at respective RF electrodes 314 .
- temperatures detected at sensor 346 provide feedback for maintaining a selected power. Temperature at sensor 346 is used as a safety means to interrupt the delivery of energy when maximum pre-set temperatures are exceeded.
- the actual temperatures are measured at temperature measurement device 408 , and the temperatures are displayed at user interface and display 402 .
- a control signal is generated by controller 404 that is proportional to the difference between an actual measured temperature and a desired temperature.
- the control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the sensor 346 .
- a multiplexer can be included to measure current, voltage and temperature, at the sensor 346 , and energy can be delivered to RF electrode 314 in monopolar or bipolar fashion.
- Controller 404 can be a digital or analog controller, or a computer with software. When controller 404 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus is a program memory and a data memory.
- Controller 404 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
- controller 404 uses the output of current sensor 396 and voltage sensor 398 to maintain a selected power level at RF electrode 314 .
- the amount of RF energy delivered controls the amount of power.
- a profile of power delivered can be incorporated in controller 404 and a preset amount of energy to be delivered may also be profiled.
- Circuitry, software and feedback to controller 404 result in process control, and the maintenance of the selected power setting that is independent of changes in voltage or current, and used to change, (i) the selected power setting, (ii) the duty cycle (on-off time), (iii) bipolar or monopolar energy delivery and (iv) fluid delivery, including flow rate and pressure.
- process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored at sensor 346 .
- Analog amplifier 410 can be a conventional differential amplifier circuit for use with sensor 346 .
- the output of analog amplifier 410 is sequentially connected by an analog multiplexer 412 to the input of AID converter 414 .
- the output of analog amplifier 410 is a voltage which represents the respective sensed temperatures.
- Digitized amplifier output voltages are supplied by AID converter 414 to microprocessor 394 .
- Microprocessor 394 may be a type 68HC11 available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.
- Microprocessor 394 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 394 corresponds to different temperatures and impedances.
- Calculated power and impedance values can be indicated on user interface and display 402 .
- calculated impedance and power values can be compared by microprocessor 394 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 402 , and additionally, the delivery of RF energy can be reduced, modified or interrupted.
- a control signal from microprocessor 394 can modify the power level supplied by energy source 392 .
- FIG. 31 illustrates a block diagram of a temperature/impedance feedback system that can be used to control the flow rate and duration of cooling fluid 100 through continuous lumen 102 to expandable and conforming members 16 , 26 and 40 and or RF electrode 314 .
- Energy is delivered to RF electrode 314 by energy source 392 , and applied to tissue site 424 .
- a monitor 416 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value, a disabling signal 418 is transmitted to energy source 392 , ceasing further delivery of energy to RF electrode 314 . If measured impedance is within acceptable limits, energy continues to be applied to the tissue.
- a comparator 420 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 420 sends a signal to a flow regulator 422 connected to an electronically controlled micropump (not shown) representing a need for an increased cooling fluid 100 flow rate, if the tissue temperature is too high, or to maintain the flow rate if the temperature has not exceeded the desired temperature.
Abstract
An apparatus includes an expandable member. The expandable member is sized to be positionable in a sphincter. An energy delivery device is positioned on a surface of the expandable member. The energy delivery device has a configuration that provides sufficient energy delivery to create lesions in the interior of the sphincter. When the expandable member is removed from the sphincter, the sphincter returns to its closed or contracted configuration.
Description
- This application is a continuation of co-pending application Ser. No. 12/315,423 filed 3 Dec. 2008, which is a divisional of U.S. application Ser. No. 10/986,687, filed Nov. 12, 2004 (now U.S. Pat. No. 7,462,179), which is a divisional of 09/911,874, filed Jul. 24, 2001 (now abandoned), which is a continuation of U.S. application Ser. No. 09/007,237, filed Jan. 14, 1998 (now abandoned).
- Gastroesophageal reflux disease (GERD) is a common gastroesophageal disorder in which the stomach contents are ejected into the lower esophagus due to a dysfunction of the lower esophageal sphincter (LES). These contents are highly acidic and potentially injurious to the esophagus resulting in a number of possible complications of varying medical severity. The reported incidence of GERD in the U.S. is as high as 10% of the population (Castell D O; Johnston B T: Gastroesophageal Reflux Disease: Current Strategies For Patient Management. Arch Fam Med, 5(4):221-7; (1996 April)).
- Acute symptoms of GERD include heartburn, pulmonary disorders and chest pain. On a chronic basis, GERD subjects the esophagus to ulcer formation, or esophagitis and may result in more severe complications including esophageal obstruction, significant blood loss and perforation of the esophagus. Severe esophageal ulcerations occur in 20-30% of patients over age 65. Moreover, GERD causes adenocarcinoma, or cancer of the esophagus, which is increasing in incidence faster than any other cancer (Reynolds J C: Influence Of Pathophysiology, Severity, And Cost On The Medical Management Of Gastroesophageal Reflux Disease. Am J Health Syst Pharm, 53(22 Suppl 3):S5-12(15 Nov. 1996)).
- Current drug therapy for GERD includes histamine receptor blockers which reduce stomach acid secretion and other drugs which may completely block stomach acid. However, while pharmacologic agents may provide short term relief, they do not address the underlying cause of LES dysfunction.
- Invasive procedures requiring percutaneous introduction of instrumentation into the abdomen exist for the surgical correction of GERD. One such procedure, Nissen fundoplication, involves constructing a new “valve” to support the LES by wrapping the gastric fundus around the lower esophagus. Although the operation has a high rate of success, it is an open abdominal procedure with the usual risks of abdominal surgery including: postoperative infection, herniation at the operative site, internal hemorrhage and perforation of the esophagus or of the cardia. In fact, a recent 10 year, 344 patient study reported the morbidity rate for this procedure to be 17% and
mortality 1% (Urschel, J D: Complications Of Antireflux Surgery, Am J Surg 166(1): 68-70; (1993 July)). This rate of complication drives up both medical cost and convalescence period for the procedure and may exclude portions of certain patient populations (e.g., the elderly and immuno-compromised). - Efforts to perform Nissen fundoplication by less invasive techniques have resulted in the development of laparoscopic Nissen fundoplication. Laparoscopic Nissen fundoplication, reported by Dallemagne et al. Surgical Laparoscopy and Endoscopy, Vol. 1, No. 3, (1991), pp. 138-43 and by Hindler et al. Surgical Laparoscopy and Endoscopy, Vol. 2, No. 3, (1992), pp. 265-272, involves essentially the same steps as Nissen fundoplication with the exception that surgical manipulation is performed through a plurality of surgical cannula introduced using trocars inserted at various positions in the abdomen.
- Another attempt to perform fundoplication by a less invasive technique is reported in U.S. Pat. No. 5,088,979. In this procedure, an invagination device containing a plurality of needles is inserted transorally into the esophagus with the needles in a refracted position. The needles are extended to engage the esophagus and fold the attached esophagus beyond the gastroesophageal junction. A remotely operated stapling device, introduced percutaneously through an operating channel in the stomach wall, is actuated to fasten the invaginated gastroesophageal junction to the surrounding involuted stomach wall.
- Yet another attempt to perform fundoplication by a less invasive technique is reported in US Pat. No. 5,676,674. In this procedure, invagination is done by a jaw-like device and fastening of the invaginated gastroesophageal junction to the fundus of the stomach is done via a transoral approach using a remotely operated fastening device, eliminating the need for an abdominal incision. However, this procedure is still traumatic to the LES and presents the postoperative risks of gastroesophageal leaks, infection and foreign body reaction, the latter two sequela resulting when foreign materials such as surgical staples are implanted in the body.
- While the methods reported above are less invasive than an open Nissen fundoplication, some still involve making an incision into the abdomen and hence the increased morbidity and mortality risks and convalescence period associated with abdominal surgery. Others incur the increased risk of infection associated with placing foreign materials into the body. All involve trauma to LES and the risk of leaks developing at the newly created gastroesophageal junction.
- There is a need in the art for a less invasive GERD treatment apparatus that does not require major surgical intervention or require the introduction of foreign materials into the body. Yet another need exists for a method of treating GERD that does not involve the medical risks of leakage and infection developing at an artificially created gastroesophageal junction. Yet another need exists for an apparatus that treats GERD with minimum trauma to the LES.
- Accordingly, an object of the invention is to provide an apparatus and method for the treatment of GERD.
- Another object of the invention is to provide an apparatus and method to treat GERD using minimally invasive surgical methods such as non-percutaneous methods.
- Yet another object of the invention is to provide an apparatus and method to treat the esophageal sphincters using minimally invasive surgical methods.
- Another object of the invention is to provide an apparatus and method to tighten the LES.
- A further other object of the invention is to provide an apparatus and method to reduce the frequency of spontaneous relaxation and opening of the LES.
- Yet another object of the invention is to provide an apparatus and method to reduce the frequency and severity of gastroesophageal reflux events.
- These and other objects of the invention are provided in an apparatus with an expandable member sized to be positionable in a sphincter. The energy delivery device is coupled to the expandable member and has a configuration that controllably produces lesions of a sufficient size, number and configuration in a sphincter so as to create a selectable tightening of the sphincter.
-
FIG. 1 is an illustrated lateral view of the upper GI tract including the esophagus and lower esophageal sphincter and the positioning of the GERD treatment apparatus of the present invention the lower esophageal sphincter. -
FIG. 2 is a lateral view of the present illustrating apertures in the expandable member. -
FIG. 3 illustrates a lateral view of an embodiment of the invention that includes two expandable members and an electrode coupled to a power source. -
FIG. 4 illustrates a lateral view of a proximal fitting and distal segments of an embodiment of the invention. -
FIG. 5 illustrates a lateral view of the deflection mechanism of the invention. -
FIG. 6A illustrates a lateral view of apertures in the expandable member and conforming member of the invention. -
FIG. 6B illustrates a lateral view of a microporous membrane used in the fabrication of the expandable member and conforming members of the invention. -
FIG. 7 is a lateral view illustrating the use of the deflection mechanism to deflect the expandable member of the present invention. -
FIG. 8 is a lateral view illustrating the use of electrolytic solution to create an enhanced RF electrode. -
FIG. 9A is a lateral view illustrating a radial distribution of electrodes on the expandable member of the invention. -
FIG. 9B is a lateral view illustrating a longitudinal distribution of electrodes on the expandable member of the invention. -
FIG. 9C is a lateral view illustrating a spiral distribution of electrodes on the expandable member of the invention. -
FIG. 10 is a lateral view illustrating the placement of electrodes on the distal segment of an embodiment the invention. -
FIG. 11 is a lateral view illustrating the placement of needle electrodes on the expandable member of an embodiment the invention. -
FIG. 12 is a lateral view illustrating the deployment of needle electrodes into the smooth muscle of the LES. -
FIG. 13 is a lateral view illustrating the position of needle electrodes in the distal segment of the expandable member. -
FIG. 14 is a flow chart illustrating the GERD treatment method of the current invention. -
FIG. 15A-C are lateral views which illustrate a technique for proper positioning of the GERD treatment apparatus in the LES. -
FIG. 16 is a lateral view of sphincter smooth muscle tissue illustrating electromagnetic foci and pathways for the origination and conduction of aberrant electrical signals in the smooth muscle of the lower esophageal sphincter. -
FIG. 17 is a lateral view illustrating a zone of electrodes of the current invention that comprises a flexible circuit that facilitates contact with the lower esophageal sphincter. -
FIG. 18 is a lateral view of the esophageal wall illustrating the infiltration of tissue healing cells into a lesion in the smooth tissue of a esophageal sphincter following treatment with the GERD treatment apparatus of the present invention. -
FIGS. 19 a and 19 b are views similar to that ofFIG. 18 illustrating shrinkage of the lesion site caused by cell infiltration. -
FIG. 20 is a lateral view of the esophageal wall illustrating the preferred placement of lesions in the smooth muscle layer of a esophageal sphincter. -
FIG. 21 is a lateral view illustrating the creation of zones of decreased porosity by sealed conforming members of an embodiment of the present invention. -
FIG. 22 is a lateral view illustrating the ultrasound transducer, ultrasound lens and ultrasound power source of an embodiment of the present invention. -
FIGS. 23A-D are lateral views of the esophageal wall illustrating various patterns of lesions created by the apparatus of the present invention. -
FIG. 24 is a lateral view of the esophageal wall illustrating the delivery of cooling fluid to the electrode-tissue interface and the creation of cooling zones. -
FIG. 25 depicts the flow path, fluid connections and control unit employed to deliver fluid to the electrode-tissue interface and electrodes. -
FIG. 26 is a lateral view illustrating the placement of cooling apertures adjacent to electrodes in the expandable member. -
FIG. 27 depicts the flow path, fluid connections and control unit employed to deliver fluid to the RF electrodes. -
FIG. 28 is an enlarged lateral view illustrating the placement of sensors on the expandable member. -
FIG. 29 depicts a block diagram of the feed back control system that can be used with the GERD treatment apparatus as shown inFIG. 3 . -
FIG. 30 depicts a block diagram of an analog amplifier, analog multiplexer and microprocessor used with the feedback control system ofFIG. 29 . -
FIG. 31 depicts a block diagram of the operations performed in the feedback control system depicted inFIG. 29 . - Referring now to
FIGS. 1 and 2 , one embodiment ofGERD treatment apparatus 10 that is used to deliver energy to atreatment site 12 to producelesions 14 in the LES includes a firstexpandable member 16 with aninterior surface 18 and anexterior surface 20. Firstexpandable member 16, which can also be an energy delivery device support member, is configured to receive anexpansion medium 22 that inflates firstexpandable member 16 from a compacted, non-deployed state to a deployed state.Exterior surface 20 includes a plurality ofapertures 24. Upon the application of sufficient pressure, firstexpandable member 16weeps expansion medium 22 frominterior surface 18. - While
expandable member 16, with a singleinterior surface 18, is preferred, it will be appreciated thatexpandable member 16 can be made of different compositions or materials, with one or more open or closed cells or chambers. The plurality of such cells or chambers can be compressed or configured in a small diameter for insertion, and are then expanded after insertion to establish the desired electrical contact with the targeted surface of the esophagus. -
Expansion medium 22 may be a gas, fluid or the like. In various embodiments, theexpansion medium 22 can be an electrolytic solution. In other embodiments,expansion medium 22 can also be a contrast solution to facilitate imaging of the procedure by fluoroscopy or ultrasonography. Yet in other embodiments,GERD treatment apparatus 10 can include visualization capability including, but not limited to a viewing scope, ultrasound, an expanded eyepiece, fiber optics (including illumination and imaging fibers), video imaging, a light source and the like. - Referring to
FIG. 3 , a secondexpandable member 26 can be positioned at least partially adjacent to firstexpandable member 16. Secondexpandable member 26 receives at least a portion of theexpansion medium 22 frominterior surface 18. - An electromagnetic
energy delivery device 28 is coupled to one of the first or secondexpandable members power source 30. - First and second
expandable members energy delivery device 28.Expandable members - Referring to
FIG. 4 , anextension member 32 with adistal segment 34 is configured to be coupled to first and/or secondexpandable members extension member 32 is rod-like and can be malleable, flexible, articulated and steerable. In various embodiments,extension member 32 can contain optics, fluid and gas paths, sensor and electronic cabling. In one embodiment,extension member 32 can be a coil-reinforced multilumen catheter, as is well known to those skilled in the art.Extension member 32 has sufficient length to position the first and second expandable members in the LES and/or stomach using a trans-oral approach. Typical lengths include, but are not limited to, a range of 40-180 cms. Aproximal fitting 36 ofextension member 32 is maneuverable by a medical practitioner. In one embodiment,extension member 32 runs through the center ofexpandable member 16 and/or 26 anddistal segment 34 that extends distally beyond the most distal expandable member.Extension member 32 may be attached to a movableproximal fitting 36 used to control deflection ofexpandable members - Referring to
FIG. 5 ,expandable members extension member 32.Expandable members deflection mechanism 38, which imparts movement of first and secondexpandable members expandable member 16 and to a movableproximal fitting 36, as is well known to those skilled in the art. - Formed spring wires can be included in first
expandable member 16 to assist in opening it to the deployed position. Optionally positioned proximal fitting contains a variety of actuators which provide a physician control ofGERD treatment apparatus 10, as more fully described hereafter. The actuators can be rocker switches, slider switches and the like, as are well known to those skilled in the art. At least portions ofGERD treatment apparatus 10 may be sufficiently radiopaque in order to be visible under fluoroscopy and/or sufficiently echogenic to be visible under ultrasonography. - One embodiment of
GERD treatment apparatus 10 is illustrated inFIG. 6A . Firstexpandable member 16 is made of a material that can be an insulator. For purposes of this disclosure, an insulator is a barrier to thermal or electrical energy flow. In this embodiment,expandable member 16 is substantially surrounded by a conformingmember 40 which is also called a fluid conduit. Conformingmember 40 receives electrolytic solution from firstexpandable member 16, heated or not heated, through a plurality ofapertures 24 formed in firstexpandable member 16, and passes it to conformingmember 40. In another embodiment, shown inFIG. 6B , firstexpandable member 16 is made of amicroporous material 42 that does not include distinct apertures. - Referring to
FIGS. 6A and 6B , conformingmember 40 is made of a material that permits controlled delivery of the electrolytic solution to thetreatment site 12 through one ormore apertures 24. In another embodiment, conformingmember 40 can be made ofmicroporous material 42 that does not include distinct apertures.Extension member 32 with first and second expandable members, or alternatively with a single expandable member, is introduced into the esophagus directly, shown inFIG. 1 , or through the use of another introducer such as an endoscope (not shown), as is more fully described hereafter with first and secondexpandable members - Referring to
FIG. 7 , firstexpandable member 16 can be deflected from side to side to facilitate maneuvering through the esophagus and positioning in the LES. This movement can be imparted bydeflection mechanism 38. - A variety of energy sources can be coupled to the porous membrane including, (i) an RF source coupled to an RF electrode, (ii) a coherent source of light coupled to an optical fiber, (iii) an incoherent light source coupled to an optical fiber, (iv) a heated fluid coupled to a catheter with an open channel configured to receive the heated fluid, (v) a heated fluid coupled to a catheter with an open channel configured to receive the heated fluid, (vi) a cooled fluid coupled to a catheter with a closed channel configured to receive the cooled fluid, (vii) a cooled fluid coupled to a catheter with an open channel configured to receive the cooled fluid, (viii) a cryogenic fluid, (ix) a resistive heating source, (x) a microwave source providing energy from 915 MHz to 2.45 GHz and coupled to a microwave antenna, (xi) an ultrasound power source coupled to an ultrasound emitter, wherein the ultrasound power source produces energy in the range of 300 KHZ to 3 GHz or (xii) a microwave source. For ease of discussion for the remainder of this application, the energy source utilized is an RF source and electromagnetic
energy delivery device 28 is a single or a plurality ofRF electrodes 44, also described aselectrodes 44. However, all of the other mentioned energy sources are equally applicable toGERD treatment apparatus 10. - For the case of RF energy,
RF electrode 44 may operated in either bipolar or monopolar mode with a ground pad electrode. In a monopolar mode of delivering RF energy, asingle electrode 44 is used in combination with an indifferent electrode patch that is applied to the body to form the other contact and complete an electrical circuit. Bipolar operation is possible when two ormore electrodes 44 are used.Multiple electrodes 44 may be used. Also, electrolytic solution serves as anenhanced RF electrode 44′ when coupled with an RF electrode 44 (refer toFIG. 8 ). - Also when the energy source is RF,
power source 30, which will now be referred to as aRF energy source 30, may have multiple channels, delivering separately modulated power to eachelectrode 44. This reduces preferential heating that occurs when more energy is delivered to a zone of greater conductivity and less heating occurs aroundelectrodes 44 which are placed into less conductive tissue. If the tissue hydration or the blood infusion in the tissue is uniform, a single channelRF energy source 30 may be used to provide power for generation oflesions 14 relatively uniform in size. - Electric current flowing through targeted smooth muscle tissue causes heating due to resistance of the tissue resulting in injury to the tissue which can be sufficient to cause the death of affected cells, also known as necrosis. For ease of discussion for the remainder of this application, cell injury will include all cellular effects resulting from the delivery of energy from the
electrode 44 up to and including cell necrosis. Cell injury can be accomplished as a relatively simple medical procedure with local anesthesia. In one embodiment, cell injury proceeds to a depth of approximately 1-4 mms from the surface of the mucosal layer. - Referring now to
FIGS. 9A-C ,electrodes 44 can cover all or a portion ofexpandable members member 40. Also,electrodes 44 may be distributed in a variety of patterns along an exterior or interior surface of eitherexpandable member member 40, in order to produce a desired placement and pattern oflesions 14. Typical electrode distribution patterns include, but are not limited, to a radial distribution 46 (refer toFIG. 9A ) or a longitudinal distribution 48 (refer toFIG. 9B ). It will be appreciated that other patterns and geometries for electrode placement, such as a spiral distribution 50 (refer toFIG. 9C ) may also be suitable. In one embodiment,electrode 44 is positioned ondistal segment 34 of extension member 32 (refer toFIG. 10 ). These electrodes may be cooled as described hereafter. Additionally,distal segment 34 may includeapertures 24 for delivery of cooling and electrolytic solution as described hereafter. -
Electrodes 44 can have a variety of shapes and sizes. Possible shapes include but are not limited to circular, rectangular, conical and pyramoidal. Electrode surfaces can be smooth or textured and concave or convex. Surface areas can range from 0.1 mm2 to 200 mm2. It will be appreciated that other geometries and surface areas may be equally suitable. In one embodiment,electrodes 44 can be in the shape of needles and of sufficient sharpness and length to penetrate into the smooth muscle of the esophageal wall. In this case,needle electrodes 52 are attached toexpandable member FIG. 11 ). During introduction of theGERD treatment apparatus 10 into the esophagus,needle electrodes 52 remain retracted inside conformingmember 40. OnceGERD treatment apparatus 10 is properly positioned at thetreatment site 12,needle electrodes 52 are deployed by expansion ofexpandable member needle electrodes 52 throughneedle apertures 54 in conformingmember 40 and into the smooth muscle tissue of the treatment site 12 (refer toFIG. 12 ). In another embodiment,distal segment 34 may also containneedle apertures 54 for protrusion ofneedle electrodes 52 into the smooth muscle of the esophageal wall. In this embodiment, shown inFIG. 13 needle electrodes 52 are coupled to an insulated guide wire 56 (known to those skilled in the art) which is advanced through aguide wire lumen 58 inextension member 32. -
FIG. 14 is a flow chart illustrating one embodiment of the operation ofGERD treatment apparatus 10. In this embodiment,GERD treatment apparatus 10 is first introduced into the esophagus under local anesthesia.GERD treatment apparatus 10 can be introduced into the esophagus by itself or through a lumen in an endoscope, such as disclosed in U.S. Pat. Nos. 5,448,990 and 5,275,608, incorporated herein by reference, or similar esophageal access device known to those skilled in the art.Expandable member gaseous expansion medium 22, such as an electrolytic solution, or a combination of both. This serves to temporarily dilate the esophagus sufficiently to efface a portion of or all of the folds of the LES. In an alternative embodiment, esophageal dilation and subsequent LES fold effacement can be accomplished by insufflation of the esophagus (a known technique) using gas introduced into the esophagus through a channel in the GERD treatment device, or an endoscope or similar esophageal access device as described above. Once treatment is completed,expandable members GERD treatment apparatus 10 is withdrawn from the esophagus. This results in the LES returning to approximately its pretreatment state and diameter. - In one embodiment, electrolytic solution is introduced into
expandable member Expandable member - Electrolytic solution in
expandable member 16 may be heated to a temperature, which can be modified and adjusted as necessary. For example, electrolytic solution can be heated and maintained at a temperature between about 65-90° C. It can be initially introduced into firstexpandable member 16 at the higher temperature, or it can be heated to the higher temperature in firstexpandable member 16. By providing a heated electrolytic solution, there is a reduction in the amount of time needed to complete a satisfactory degree of tissue injury of targeted cells. - It is important to have proper positioning of the
expandable members member 40 in the sphincter during both diagnosis and treatment phases. This can be facilitated by the following procedure: (I) carefully advancing one or both ofexpandable members GERD treatment apparatus 10 proximally until resistance is encountered. This procedure is illustrated inFIGS. 15A-C . - The diagnostic phase then begins. This is achieved through a variety of diagnostic methods, including, but not limited to, the following: (I) visualization of the interior surface of the esophagus via an endoscope or other viewing apparatus inserted into the esophagus, (ii) visualization of the interior morphology of the esophageal wall using ultrasonography to establish a baseline for the tissue to be treated, (iii) impedance measurement to determine the electrical conductivity between the esophageal mucosal layers and
GERD treatment apparatus 10 and (iv) measurement and surface mapping of the electropotential of the LES during varying time periods which may include such events as depolarization, contraction and repolarization of LES smooth muscle tissue. This latter technique is done to determine specific sites in the LES to be treated which are acting asfoci 60 orpathways 62 for abnormal or inappropriate polarization and relaxation of the smooth muscle of the LES (Refer toFIG. 16 ). - In the treatment phase, the delivery of energy of the targeted site can be conducted under feedback control, manually or a combination of both. Feedback control enables
GERD treatment apparatus 10 to be positioned and retained in the esophagus during treatment with minimal attention by the physician. When positioned at the LES,GERD treatment apparatus 10 provides a relatively even flow of heated electrolytic solution to facilitate the cell injury process. As shown inFIG. 17 ,GERD treatment apparatus 10 also may have a plurality ofelectrodes 44 contained in zones that effectively create aflexible circuit 64 which in turn, facilitates contact of theelectrode 44 with all or a portion of the interior surface areas of the LES.Electrodes 44 can be multiplexed in order to treat the targeted site or only a portion thereof. Feedback can be included and is achieved by, (I) visualization, (ii) impedance measurement, (iii) ultrasonography, (iv) temperature measurement; and, (v) sphincter contractile force measurement via manometry. The feedback mechanism permits the selected on-off switching ofdifferent electrodes 44 of theflexible circuit 64 in a desired pattern, which can be sequential from oneelectrode 44 to anadjacent electrode 44, or can jump around betweennon-adjacent electrodes 44.Individual electrodes 44 are multiplexed and volumetrically controlled by a controller. - The area and magnitude of cell injury in the LES can vary. However, it is desirable to deliver sufficient energy to the targeted
treatment site 12 to be able to achieve tissue temperatures in the range of 55-95° C. and producelesions 14 at depths ranging from 1-4 mm from the interior surface of the LES. Typical energies delivered to the esophageal wall include, but are not limited to, a range between 100 and 50,000 joules perelectrode 44. It is also desirable to deliver sufficient energy such that the resultinglesions 14 have a sufficient magnitude and area of cell injury to cause an infiltration oflesion 14 byfibroblasts 66,myofibroblasts 68,macrophages 70 and other cells involved in the tissue healing process (refer toFIG. 18 ). As shown inFIGS. 19A and B, these cells cause a contraction of tissue aroundlesion 14, decreasing its volume and, or altering the biomechanical properties atlesion 14 so as to result in a tightening of LES. These changes are reflected in transformedlesion 14′ shown in 19B. The diameter oflesions 14 can vary between 0.1 to 4 mm. It is preferable thatlesions 14 are less than 4 mm in diameter in order to reduce the risk of thermal damage to the mucosal layer. In one embodiment, a 2mm diameter lesion 14 centered in the wall of the smooth muscle provides a 1 mm buffer zone to prevent damage to the mucosa, submucosa and adventia, while still allowing for cell infiltration and subsequent tightening on approximately 50% of the thickness of the wall of the smooth muscle (refer toFIG. 20 ). - In one embodiment,
GERD treatment apparatus 10 conforms tightly with the interior of the esophagus so that all, or nearly all, of the interior circumference of a desired segment of the LES is in contact with a surface of conformingmember 40. Conformingmember 40 is fitted into the entire LES andexpandable member 16 does not have to be moved about the esophagus to complete the treatment. Alternatively,GERD treatment apparatus 10 may not entirely fill the esophagus, andGERD treatment apparatus 10 is then moved about the esophagus in order to treat all of the esophagus, or those sections where tightening of the lower esophageal sphincter is desired. - Conforming
member 40 is made of a material that substantially conforms to the surface of the LES and, or other sphincters. This provides better conformity than the mere use ofexpandable member 16. As a result, the delivery of treatment energy to the LES is enhanced. Energy delivery may also be enhanced by use of a conductingsurface 72 which may cover all, or part of, the exterior of conformingmember 40. The surface of conformingmember 40 can be made conductive by a variety of means including, but not limited to chemical coating with a conductive material, implantation with conductive ions and application of a conductive film. - Conforming
member 40 can have a thickness in the range of about 0.01 to 2.0 cm. Conformingmember 40 can be made of a foam type material. Suitable materials include, but are not limited to, knitted polyester, continuous filament polyester, polyester-cellulose, rayon, polyamide, polyurethane, polyethylene, silicone, and the like. Suitable commercial foams include, (i) Opcell, available from Sentinel Products Corp., Hyannis, Massachusetts and (ii) UltraSorb, HT 4201 or HT 4644MD from Wilshire Contamination Control, Carlsbad, Calif. Conformingmember 40 has characteristics that make it particularly moldable and formable to irregular surfaces. In one embodiment, conformingmember 40 is made of an open cell foam, or alternatively it can be a thermoplastic film such as polyurethane, low density polyethylene, or it may be a silicone. Additionally, conformingmember 40 can be capable of extruding conductive materials from conformingmember 40 itself. -
FIG. 21 illustrates that conformingmember 40 can be created by sealing two smaller conformingmembers members individual electrodes 44. This creates a pocket orzone 78.Zone 78 has a lower porosity for the flow of electrolytic solution thannon-zone sections 80, e.g., all other sections of conformingmember 40 which do not include azone 78 with an associatedelectrode 44. The porosity ofnon-zone sections 80 is greater than the porosity ofzones 78. - From a diagnostic standpoint, it is desirable to image the
interior surface 18 and wall of the LES including the size and position of createdlesions 14. It is desirable to create a map of these structures which can input to a controller and used to direct the delivery of energy to the treatment site. Referring toFIG. 22 , this can be accomplished through the use of ultrasonography (a known procedure) which involves the use of anultrasound power source 82 coupled to one ormore ultrasound transducers 84 that are positioned in or onexpandable member member 40. An output is associated withultrasound power source 82 andRF energy source 30. - Each
ultrasound transducer 84 can include apiezoelectric crystal 86 mounted on abacking material 88 that is in turn attached toexpandable members member 40. Anultrasound lens 90, fabricated on an electrically insulatingmaterial 92, is mounted over thepiezoelectric crystal 86 Thepiezoelectric crystal 86 is connected by electrical leads toultrasound power source 82. Eachultrasound transducer 84 transmits ultrasound energy through conformingmember 40 orexpandable members Ultrasound transducers 84 can be in the form of an imaging probe such as Model 21362, manufactured and sold by Hewlett Packard Company, Palo Alto, Calif. In one embodiment, twoultrasound transducers 84 are positioned on opposite sides ofexpandable member 16 to create an image depicting the size and position oflesion 14 in the LES. - It is desirable that
lesions 14 are predominantly located in the smooth muscle layer of esophageal wall at the depths ranging from 1 to 4 mms from the interior surface of the sphincter. However,lesions 14 can vary both in number and position within the sphincter wall. It may be desirable to produce a pattern ofmultiple lesions 14 within the esophageal smooth muscle in order to obtain a selected degree of tightening of the LES. Typical lesion patterns shown inFIGS. 23A-C include but are not limited to, (i) a concentric circle oflesions 14 all at fixed depth in the smooth muscle layer evenly spaced along the radial axis of the LES, (ii) a wavy or folded circle oflesions 14 at varying depths in the smooth muscle layer evenly spaced along the radial axis of the LES, (iii)lesions 14 randomly distributed at varying depths in the smooth muscle, but evenly spaced in a radial direction; and, (iv) an eccentric pattern oflesions 14 in one or more radial locations in the smooth muscle wall. Accordingly, the depth of RF and thermal energy penetration in the lower esophageal sphincter is controlled and selectable. The selective application of energy to the lower esophageal sphincter may be the even penetration of RF energy to the entire targeted site, a portion of it, or applying different amounts of RF energy to different sites depending on the condition of the sphincter. If desired, the area of cell injury can be substantially the same for every treatment event. - Referring to
FIG. 24 , it may be desirable to cool all or a portion of the area near the electrode-tissue interface 96 before during and after the delivery of energy in order to reduce the degree and area of cell injury. Specifically the use of cooling preserves the mucosal layers and protects or otherwise reduces the degree of cell damage to cooledzone 98 in the vicinity of thelesion 14. This can be accomplished through the use of a cooling fluid 100 that weeps out of theexpandable members member 40 which is in fluid communication with acontinuous lumen 102 inextension member 32 that is, in turn, in fluid communication withfluid reservoir 104 and acontrol unit 106, whose operation will be described hereafter that controls the delivery of the fluid (Refer toFIG. 25 ). All or only a portion ofelectrode 44 may also be cooled. - Similarly, it may also be desirable to cool all or a portion of the
electrode 44. The rapid delivery of heat throughelectrode 44, may result in the build up of charred biological matter on electrode 44 (from contact with tissue and fluids e.g. blood) that impedes the flow of both thermal and electrical energy fromelectrode 44 to adjacent tissue and causes an electrical impedance rise beyond a cutoff value set onRF energy source 30. A similar situation may result from the desiccation of tissue adjacent toelectrode 44. Cooling of theelectrode 44 can be accomplished by cooling fluid 100 that weeps out ofexpandable members 16 and/or 26 and conformingmember 40 as described previously. In another embodiment,expandable member 16 may contain a plurality of coolingapertures 108 adjacent or directed towardelectrode 44 to enhance the flow of cooling solution and, or cooling rate ofelectrode 44 and adjacent tissue (refer toFIG. 26 ). Referring now toFIG. 27 , electrode may also be cooled via afluid channel 110 inelectrode 44 that is in fluid communication withfluid reservoir 104 andcontrol unit 106 via thecontinuous lumen 102 inextension member 32 as described previously. - As shown in
FIG. 28 . one ormore sensors 112 may be positioned adjacent or onelectrode 44 for sensing the temperature of esophageal tissue attreatment site 12. More specifically,sensors 112 permit accurate determination of the surface temperature of the esophagus at electrode-tissue interface 96. This information can be used to regulate both the delivery of energy and cooling solution to the interior surface of the esophagus. Invarious embodiments sensors 112 can be positioned at any position onexpandable members member 40. Suitable sensors that may be used forsensor 112 include: thermocouples, fiber optics, resistive wires, thermocouple IR detectors, and the like. Suitable thermocouples forsensor 112 include: T type with copper constantene, J type, E type and K types as are well known those skilled in the art. - Temperature data from
sensors 112 are fed back tocontrol unit 106 and through an algorithm which is stored within a microprocessor memory ofcontrol unit 106. Instructions are sent to an electronically controlled micropump (not shown) to deliver fluid through the fluid lines at the appropriate flow rate and duration to provide control temperature at the electrode-tissue interface 96 (refer toFIG. 28 ). - The reservoir of
control unit 106 may have the ability to control the temperature of the coolingfluid 100 by either cooling the fluid or heating the fluid. Alternatively, afluid reservoir 104 of sufficient size may be used in which the coolingfluid 100 is introduced at a temperature at or near that of the normal body temperature. Using a thermally insulatedreservoir 114, adequate control of the tissue temperature may be accomplished without need of refrigeration or heating of the coolingfluid 100. Cooling fluid 100 flow is controlled bycontrol unit 106 or another feedback control system (described herein) to provide temperature control at the electrode-tissue interface 96. - A second diagnostic phase may be included after the treatment is completed. This provides an indication of lower esophageal tightening treatment success, and whether or not a second phase of treatment, to all or only a portion of the esophagus, now or at some later time, should be conducted. The second diagnostic phase is accomplished through, (I) visualization, (ii) measuring impedance, (iii) ultrasonography or (iv) temperature measurement, (v) measurement of LES tension and contractile force via manometry.
- In one embodiment,
GERD treatment apparatus 10 is coupled to an open or closed loop feedback system. Referring now toFIG. 29 , an open or closed loop feedback system couplessensor 346 toenergy source 392. In this embodiment,RF electrode 314 is one ormore RF electrodes 314. - The temperature of the tissue, or of
RF electrode 314 is monitored, and the output power ofenergy source 392 adjusted accordingly. The physician can, if desired, override the closed or open loop system. A microprocessor can be included and incorporated in the closed or open loop system to switch power on and off, as well as modulate the power. The closed loop system utilizes amicroprocessor 394 to serve as a controller, monitor the temperature, adjust the RF power, analyze at the result, refeed the result, and then modulate the power. - With the use of
sensor 346 and the feedback control system a tissue adjacent toRF electrode 314 can be maintained at a desired temperature for a selected period of time without impeding out. EachRF electrode 314 is connected to resources which generate an independent output. The output maintains a selected energy atRF electrode 314 for a selected length of time. - Current delivered through
RF electrode 314 is measured bycurrent sensor 396. Voltage is measured byvoltage sensor 398. Impedance and power are then calculated at power andimpedance calculation device 400. These values can then be displayed at user interface anddisplay 402. Signals representative of power and impedance values are received by acontroller 404. - A control signal is generated by
controller 404 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used bypower circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired power delivered atrespective RF electrodes 314. - In a similar manner, temperatures detected at
sensor 346 provide feedback for maintaining a selected power. Temperature atsensor 346 is used as a safety means to interrupt the delivery of energy when maximum pre-set temperatures are exceeded. The actual temperatures are measured attemperature measurement device 408, and the temperatures are displayed at user interface anddisplay 402. A control signal is generated bycontroller 404 that is proportional to the difference between an actual measured temperature and a desired temperature. The control signal is used bypower circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at thesensor 346. A multiplexer can be included to measure current, voltage and temperature, at thesensor 346, and energy can be delivered toRF electrode 314 in monopolar or bipolar fashion. -
Controller 404 can be a digital or analog controller, or a computer with software. Whencontroller 404 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus is a program memory and a data memory. - User interface and
display 402 includes operator controls and a display.Controller 404 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized. - The output of
current sensor 396 andvoltage sensor 398 is used bycontroller 404 to maintain a selected power level atRF electrode 314. The amount of RF energy delivered controls the amount of power. A profile of power delivered can be incorporated incontroller 404 and a preset amount of energy to be delivered may also be profiled. - Circuitry, software and feedback to
controller 404 result in process control, and the maintenance of the selected power setting that is independent of changes in voltage or current, and used to change, (i) the selected power setting, (ii) the duty cycle (on-off time), (iii) bipolar or monopolar energy delivery and (iv) fluid delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored atsensor 346. - As illustrated in
FIG. 30 ,current sensor 396 andvoltage sensor 398 are connected to the input of ananalog amplifier 410.Analog amplifier 410 can be a conventional differential amplifier circuit for use withsensor 346. The output ofanalog amplifier 410 is sequentially connected by ananalog multiplexer 412 to the input ofAID converter 414. The output ofanalog amplifier 410 is a voltage which represents the respective sensed temperatures. Digitized amplifier output voltages are supplied byAID converter 414 tomicroprocessor 394.Microprocessor 394 may be a type 68HC11 available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature. -
Microprocessor 394 sequentially receives and stores digital representations of impedance and temperature. Each digital value received bymicroprocessor 394 corresponds to different temperatures and impedances. - Calculated power and impedance values can be indicated on user interface and
display 402. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared bymicroprocessor 394 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface anddisplay 402, and additionally, the delivery of RF energy can be reduced, modified or interrupted. A control signal frommicroprocessor 394 can modify the power level supplied byenergy source 392. -
FIG. 31 illustrates a block diagram of a temperature/impedance feedback system that can be used to control the flow rate and duration of cooling fluid 100 throughcontinuous lumen 102 to expandable and conformingmembers RF electrode 314. Energy is delivered toRF electrode 314 byenergy source 392, and applied totissue site 424. Amonitor 416 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value, a disabling signal 418 is transmitted toenergy source 392, ceasing further delivery of energy toRF electrode 314. If measured impedance is within acceptable limits, energy continues to be applied to the tissue. During the application ofenergy sensor 346 measures the temperature of tissue and/orRF electrode 314. A comparator 420 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 420 sends a signal to aflow regulator 422 connected to an electronically controlled micropump (not shown) representing a need for an increasedcooling fluid 100 flow rate, if the tissue temperature is too high, or to maintain the flow rate if the temperature has not exceeded the desired temperature. - The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.
Claims (4)
1. A method of treating a lower esophageal sphincter, comprising:
providing an expandable member sized to be positionable at or near a lower esophageal sphincter in a compacted condition and being sized and configured to expand to an expanded condition to non-permanently dilate the lower esophageal sphincter, and an energy delivery device coupled to the expandable member comprising at least one tissue-piercing needle electrode sized and configured for deployment between a retracted position and an extended position,
coupling a source of radio-frequency energy to the energy delivery device,
introducing the expandable member to a tissue region at or near the lower esophageal sphincter in the compacted condition and with the at least one tissue-piercing needle electrode in the retracted position,
expanding the expandable member to the expanded condition to dilate the lower esophageal sphincter,
deploying the at least one tissue-piercing needle electrode to the extended position to pierce sub-mucosal tissue at or near the lower esophageal sphincter,
delivering energy from the source of radio-frequency energy to the at least one needle-piercing electrode to cause necrosis of the sub-mucosal tissue due to resistance heating at or near the lower esophageal sphincter and produce at least one sub-mucosal lesion to thereby selectively tighten the lower esophageal sphincter,
sensing a temperature condition at the tissue region, and
delivering a cooling fluid to the tissue region based, at least in part, upon the temperature condition that is sensed, to preserve mucosal tissue.
2. The method of claim 1
wherein the energy delivery device includes a plurality of tissue-piercing needle electrodes configured for deployment between a retracted position and an extended position,
wherein deploying deploys the plurality of tissue-piercing needle electrodes to the extended position to pierce sub-mucosal tissue at or near the lower esophageal sphincter, and
wherein delivering energy delivers radio-frequency energy to the plurality of tissue-piercing needle electrodes to produce a plurality of sub-mucosal lesions.
3. The method of claim 1
wherein the expandable member is a balloon.
4. The method of claim 1
further including returning the expandable member to the compacted condition and the at least one tissue-piercing electrode to the retracted position, and removing the expandable member from the tissue region.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/327,105 US20120089138A1 (en) | 1998-01-14 | 2011-12-15 | Gerd treatment apparatus and method |
US13/958,542 US20130317497A1 (en) | 1998-01-14 | 2013-08-03 | Gerd treatment apparatus and method |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US723798A | 1998-01-14 | 1998-01-14 | |
US09/911,874 US20020115991A1 (en) | 1994-06-24 | 2001-07-24 | Gerd treatment apparatus and method |
US10/986,687 US7462179B2 (en) | 1998-01-14 | 2004-11-12 | GERD treatment apparatus and method |
US12/315,423 US20090131928A1 (en) | 1998-01-14 | 2008-12-03 | GERD treatment apparatus and method |
US13/327,105 US20120089138A1 (en) | 1998-01-14 | 2011-12-15 | Gerd treatment apparatus and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/315,423 Continuation US20090131928A1 (en) | 1998-01-14 | 2008-12-03 | GERD treatment apparatus and method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/958,542 Continuation US20130317497A1 (en) | 1998-01-14 | 2013-08-03 | Gerd treatment apparatus and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120089138A1 true US20120089138A1 (en) | 2012-04-12 |
Family
ID=21725002
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/911,874 Abandoned US20020115991A1 (en) | 1994-06-24 | 2001-07-24 | Gerd treatment apparatus and method |
US10/986,687 Expired - Fee Related US7462179B2 (en) | 1998-01-14 | 2004-11-12 | GERD treatment apparatus and method |
US12/315,423 Abandoned US20090131928A1 (en) | 1998-01-14 | 2008-12-03 | GERD treatment apparatus and method |
US13/327,105 Abandoned US20120089138A1 (en) | 1998-01-14 | 2011-12-15 | Gerd treatment apparatus and method |
US13/958,542 Abandoned US20130317497A1 (en) | 1998-01-14 | 2013-08-03 | Gerd treatment apparatus and method |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/911,874 Abandoned US20020115991A1 (en) | 1994-06-24 | 2001-07-24 | Gerd treatment apparatus and method |
US10/986,687 Expired - Fee Related US7462179B2 (en) | 1998-01-14 | 2004-11-12 | GERD treatment apparatus and method |
US12/315,423 Abandoned US20090131928A1 (en) | 1998-01-14 | 2008-12-03 | GERD treatment apparatus and method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/958,542 Abandoned US20130317497A1 (en) | 1998-01-14 | 2013-08-03 | Gerd treatment apparatus and method |
Country Status (6)
Country | Link |
---|---|
US (5) | US20020115991A1 (en) |
EP (1) | EP1047348A1 (en) |
JP (1) | JP2002508989A (en) |
AU (1) | AU2224499A (en) |
CA (1) | CA2318315A1 (en) |
WO (1) | WO1999035986A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6056744A (en) * | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US6464697B1 (en) * | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
AU2317899A (en) * | 1998-01-14 | 1999-08-02 | Conway-Stuart Medical, Inc. | Gerd treatment apparatus and method |
AU2114299A (en) | 1998-01-14 | 1999-08-02 | Conway-Stuart Medical, Inc. | Electrosurgical device for sphincter treatment |
CA2319517A1 (en) | 1998-02-19 | 1999-08-26 | Curon Medical, Inc. | Electrosurgical sphincter treatment apparatus |
US6514245B1 (en) * | 1999-03-15 | 2003-02-04 | Cryovascular Systems, Inc. | Safety cryotherapy catheter |
US6432102B2 (en) | 1999-03-15 | 2002-08-13 | Cryovascular Systems, Inc. | Cryosurgical fluid supply |
US20040215235A1 (en) * | 1999-11-16 | 2004-10-28 | Barrx, Inc. | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
WO2001035846A1 (en) * | 1999-11-16 | 2001-05-25 | Ganz Robert A | System and method of treating abnormal tissue in the human esophagus |
US20060095032A1 (en) * | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US6529756B1 (en) * | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
WO2001066018A1 (en) * | 2000-03-03 | 2001-09-13 | C. R. Bard, Inc. | Endoscopic tissue apposition device with multiple suction ports |
US7811282B2 (en) | 2000-03-06 | 2010-10-12 | Salient Surgical Technologies, Inc. | Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof |
US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
US6689131B2 (en) | 2001-03-08 | 2004-02-10 | Tissuelink Medical, Inc. | Electrosurgical device having a tissue reduction sensor |
ES2643763T3 (en) | 2000-03-06 | 2017-11-24 | Salient Surgical Technologies, Inc. | Fluid supply system and controller for electrosurgical devices |
US8048070B2 (en) | 2000-03-06 | 2011-11-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices, systems and methods |
EP1642544B1 (en) | 2000-05-03 | 2009-04-08 | C.R.Bard, Inc. | Apparatus for mapping and ablation in electrophysiology procedures |
ES2435094T3 (en) | 2000-05-19 | 2013-12-18 | C.R. Bard, Inc. | Device and method of tissue capture and suturing |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
AU2001263143B2 (en) * | 2000-11-16 | 2006-12-07 | Covidien Lp | System and method of treating abnormal tissue in the human esophagus |
US6699243B2 (en) | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US7097644B2 (en) | 2001-03-30 | 2006-08-29 | Ethicon Endo-Surgery, Inc. | Medical device with improved wall construction |
US20020183739A1 (en) | 2001-03-30 | 2002-12-05 | Long Gary L. | Endoscopic ablation system with sealed sheath |
JP4780543B2 (en) * | 2001-09-19 | 2011-09-28 | Hoya株式会社 | Endoscope balloon device |
US7615049B2 (en) | 2001-09-19 | 2009-11-10 | Mederi Therapeutics, Inc. | Devices, systems and methods for treating tissue regions of the body |
US7137981B2 (en) | 2002-03-25 | 2006-11-21 | Ethicon Endo-Surgery, Inc. | Endoscopic ablation system with a distally mounted image sensor |
US6755849B1 (en) | 2002-03-28 | 2004-06-29 | Board Of Regents, The University Of Texas System | Method for delivering energy to tissue and apparatus |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
WO2004039416A2 (en) | 2002-10-29 | 2004-05-13 | Tissuelink Medical, Inc. | Fluid-assisted electrosurgical scissors and methods |
JP4486345B2 (en) * | 2003-07-22 | 2010-06-23 | トキコーポレーション株式会社 | Artificial esophagus |
DE10345023A1 (en) * | 2003-09-24 | 2005-04-21 | Biotronik Gmbh & Co Kg | Ablation catheter, comprising electrode holding elements in radial extended position when released |
US7150745B2 (en) | 2004-01-09 | 2006-12-19 | Barrx Medical, Inc. | Devices and methods for treatment of luminal tissue |
US7727232B1 (en) | 2004-02-04 | 2010-06-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices and methods |
JP5065005B2 (en) * | 2004-04-01 | 2012-10-31 | ザ ジェネラル ホスピタル コーポレイション | Method and apparatus for dermatological treatment and tissue remodeling |
US20080082090A1 (en) * | 2004-04-01 | 2008-04-03 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
EP1742590B1 (en) * | 2004-04-05 | 2018-06-13 | The General Hospital Corporation | Device for treating tissue |
US7232438B2 (en) | 2004-07-09 | 2007-06-19 | Ethicon Endo-Surgery, Inc. | Ablation device with clear probe |
US10646109B1 (en) * | 2004-07-19 | 2020-05-12 | Hypermed Imaging, Inc. | Device and method of balloon endoscopy |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
WO2007014003A2 (en) | 2005-07-22 | 2007-02-01 | The Foundry Inc. | Systems and methods for delivery of a therapeutic agent |
US7819817B2 (en) * | 2005-09-21 | 2010-10-26 | Siemens Aktiengesellschaft | Temperature probe for insertion into the esophagus |
US7959627B2 (en) | 2005-11-23 | 2011-06-14 | Barrx Medical, Inc. | Precision ablating device |
US8702694B2 (en) | 2005-11-23 | 2014-04-22 | Covidien Lp | Auto-aligning ablating device and method of use |
US7997278B2 (en) | 2005-11-23 | 2011-08-16 | Barrx Medical, Inc. | Precision ablating method |
GB0523917D0 (en) | 2005-11-24 | 2006-01-04 | Femeda Ltd | Devices for electrostimulation |
GB0523918D0 (en) | 2005-11-24 | 2006-01-04 | Femeda Ltd | Self contained device with treatment cycle for electrostimulation |
GB0523916D0 (en) * | 2005-11-24 | 2006-01-04 | Femeda Ltd | Compressible electrodes |
US20070142699A1 (en) * | 2005-12-16 | 2007-06-21 | Acoustx Corporation | Methods and implantable apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease |
US20070142884A1 (en) * | 2005-12-16 | 2007-06-21 | Acoustx Corporation | Methods and apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
GB0620061D0 (en) * | 2006-10-10 | 2006-11-22 | Medical Device Innovations Ltd | Oesophageal treatment apparatus and method |
WO2008137757A1 (en) | 2007-05-04 | 2008-11-13 | Barrx Medical, Inc. | Method and apparatus for gastrointestinal tract ablation for treatment of obesity |
US8784338B2 (en) | 2007-06-22 | 2014-07-22 | Covidien Lp | Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size |
WO2009009443A1 (en) | 2007-07-06 | 2009-01-15 | Barrx Medical, Inc. | Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation |
US20090012518A1 (en) * | 2007-07-06 | 2009-01-08 | Utley David S | Method and Apparatus for Ablation of Benign, Pre-Cancerous and Early Cancerous Lesions That Originate Within the Epithelium and are Limited to the Mucosal Layer of the Gastrointestinal Tract |
EP2170202A1 (en) * | 2007-07-06 | 2010-04-07 | Barrx Medical, Inc. | Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding |
US8646460B2 (en) * | 2007-07-30 | 2014-02-11 | Covidien Lp | Cleaning device and methods |
US8273012B2 (en) | 2007-07-30 | 2012-09-25 | Tyco Healthcare Group, Lp | Cleaning device and methods |
US20090254142A1 (en) * | 2008-04-08 | 2009-10-08 | Silhouette Medical, Usa | Treating Medical Conditions of Hollow Organs |
US20090318914A1 (en) * | 2008-06-18 | 2009-12-24 | Utley David S | System and method for ablational treatment of uterine cervical neoplasia |
US9629678B2 (en) | 2008-12-30 | 2017-04-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Controlled irrigated catheter ablation systems and methods thereof |
US8702693B2 (en) * | 2009-02-17 | 2014-04-22 | Boston Scientific Scimed, Inc. | Apparatus and methods for supplying fluid to an electrophysiology apparatus |
JP5444840B2 (en) * | 2009-05-21 | 2014-03-19 | 東レ株式会社 | Ablation catheter with balloon and ablation catheter system with balloon |
JP2011099631A (en) * | 2009-11-06 | 2011-05-19 | Denso Corp | Heat exchanger |
US20110152857A1 (en) * | 2009-12-19 | 2011-06-23 | Frank Ingle | Apparatus and Methods For Electrophysiology Procedures |
US20110160726A1 (en) * | 2009-12-30 | 2011-06-30 | Frank Ingle | Apparatus and methods for fluid cooled electrophysiology procedures |
WO2011127216A2 (en) * | 2010-04-06 | 2011-10-13 | Innovative Pulmonary Solutions, Inc. | System and method for pulmonary treatment |
GB2535657A (en) * | 2010-07-13 | 2016-08-24 | Sandhill Scient Inc | Apparatus and method for detecting and measuring condition of esophageal mucosa and indications of gastroesophageal reflux disease |
US20120029512A1 (en) * | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
CN102429721B (en) * | 2010-09-29 | 2015-08-26 | 心诺普医疗技术(北京)有限公司 | A kind of ablation system |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
KR102291972B1 (en) * | 2011-01-19 | 2021-08-23 | 프랙틸 헬쓰, 인코포레이티드 | Devices and methods for the treatment of tissue |
US10278774B2 (en) | 2011-03-18 | 2019-05-07 | Covidien Lp | Selectively expandable operative element support structure and methods of use |
EP2796103B1 (en) | 2011-08-25 | 2017-02-22 | Covidien LP | Systems and devices for treatment of luminal tissue |
WO2013052501A1 (en) | 2011-10-05 | 2013-04-11 | Innovative Pulmonary Solutions, Inc. | Apparatus for injuring nerve tissue |
US8403927B1 (en) | 2012-04-05 | 2013-03-26 | William Bruce Shingleton | Vasectomy devices and methods |
US9883906B2 (en) | 2012-04-22 | 2018-02-06 | Newuro, B.V. | Bladder tissue modification for overactive bladder disorders |
CN104379212B (en) | 2012-04-22 | 2016-08-31 | 纽乌罗有限公司 | Bladder body for overactive bladder changes |
US10610294B2 (en) | 2012-04-22 | 2020-04-07 | Newuro, B.V. | Devices and methods for transurethral bladder partitioning |
US9675414B2 (en) | 2012-09-13 | 2017-06-13 | Boston Scientific Scimed, Inc. | Renal nerve modulation balloon and methods of making and using the same |
US20150080867A1 (en) * | 2012-09-19 | 2015-03-19 | Wolfgang Neuberger | Gastric Reflux Treatment with Lasers |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10492849B2 (en) * | 2013-03-15 | 2019-12-03 | Cynosure, Llc | Surgical instruments and systems with multimodes of treatments and electrosurgical operation |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
WO2014143898A1 (en) | 2013-03-15 | 2014-09-18 | Holaira, Inc. | Systems, devices, and methods for treating a pulmonary disorder with an agent |
US10098694B2 (en) | 2013-04-08 | 2018-10-16 | Apama Medical, Inc. | Tissue ablation and monitoring thereof |
US10349824B2 (en) | 2013-04-08 | 2019-07-16 | Apama Medical, Inc. | Tissue mapping and visualization systems |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
WO2015002787A1 (en) | 2013-07-01 | 2015-01-08 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3019105B1 (en) | 2013-07-11 | 2017-09-13 | Boston Scientific Scimed, Inc. | Devices for nerve modulation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
CN105682594B (en) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | Helical bipolar electrodes renal denervation dominates air bag |
EP3024406B1 (en) | 2013-07-22 | 2019-06-19 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3024405A1 (en) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
WO2015027096A1 (en) | 2013-08-22 | 2015-02-26 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10568686B2 (en) | 2013-11-21 | 2020-02-25 | Biosense Webster (Israel) Ltd. | Multi-electrode balloon catheter with circumferential and point electrodes |
EP3091922B1 (en) | 2014-01-06 | 2018-10-17 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
EP3424453A1 (en) | 2014-02-04 | 2019-01-09 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
EP3125998B1 (en) * | 2014-04-02 | 2017-08-09 | Koninklijke Philips N.V. | Body illumination device |
CN106572842A (en) * | 2014-06-24 | 2017-04-19 | 阿帕玛医疗公司 | Tissue ablation and monitoring thereof |
GB201414695D0 (en) | 2014-08-19 | 2014-10-01 | Femeda Ltd | Electrostimulation related devices and methods |
PL227986B1 (en) * | 2014-11-07 | 2018-02-28 | Medinice Społka Akcyjna | Multipurpose, electrophysiological diagnostic catheter for treatments in electrocardiology |
WO2016090122A1 (en) | 2014-12-03 | 2016-06-09 | PAVmed Inc. | Systems and methods for percutaneous division of fibrous structures |
US10105531B2 (en) | 2015-09-07 | 2018-10-23 | Femeda Ltd. | Device for electrostimulation |
US20170105793A1 (en) * | 2015-10-15 | 2017-04-20 | Boston Scientific Scimed, Inc. | Energy delivery devices and related methods of use |
EP4302713A3 (en) | 2015-11-16 | 2024-03-13 | Boston Scientific Scimed, Inc. | Energy delivery devices |
EP3708111A1 (en) | 2016-03-22 | 2020-09-16 | DENTSPLY SIRONA Inc. | Method and arrangement for cleaning of a canal |
WO2019133606A1 (en) * | 2017-12-26 | 2019-07-04 | Gala Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of disease states and disorders |
US11432870B2 (en) | 2016-10-04 | 2022-09-06 | Avent, Inc. | Cooled RF probes |
US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
US11045648B2 (en) | 2017-11-14 | 2021-06-29 | Boston Scientific Scimed, Inc. | Irreversible electroporation through a combination of substance injection and electrical field application |
JP2021508533A (en) | 2017-12-26 | 2021-03-11 | ギャラリー,インコーポレイテッド | Optimizing energy delivery for a variety of applications |
CN111615371B (en) | 2018-01-23 | 2024-02-27 | 波士顿科学国际有限公司 | Enhanced needle array and treatment for tumor ablation |
AU2019217623B2 (en) | 2018-02-07 | 2021-10-28 | Cynosure, Inc. | Methods and apparatus for controlled RF treatments and RF generator system |
US11246644B2 (en) | 2018-04-05 | 2022-02-15 | Covidien Lp | Surface ablation using bipolar RF electrode |
US11291382B2 (en) | 2018-06-01 | 2022-04-05 | Diversatek Healthcare, Inc. | System and method for detecting and measuring the condition of intraluminal esophageal mucosa |
US20210007796A1 (en) * | 2019-07-10 | 2021-01-14 | Zidan Medical, Inc. | Systems, devices and methods for treating lung tumors |
USD1005484S1 (en) | 2019-07-19 | 2023-11-21 | Cynosure, Llc | Handheld medical instrument and docking base |
CN110433347B (en) * | 2019-08-12 | 2021-08-24 | 南通市第二人民医院 | Neurogenic bladder auxiliary device |
CN114945338A (en) | 2019-10-15 | 2022-08-26 | 波士顿科学国际有限公司 | Control system and user interface for an ablation system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197022B1 (en) * | 1996-07-30 | 2001-03-06 | James A. Baker | Medical instruments and techniques for treatment of gastro-esophageal reflux disease |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US505730A (en) * | 1893-09-26 | Telephone-circuit | ||
US1798902A (en) | 1928-11-05 | 1931-03-31 | Edwin M Raney | Surgical instrument |
US3517128A (en) | 1968-02-08 | 1970-06-23 | James R Hines | Surgical expanding arm dilator |
US3801241A (en) * | 1973-02-08 | 1974-04-02 | Micropump Corp | Pump impeller construction |
US3901241A (en) | 1973-05-31 | 1975-08-26 | Al Corp Du | Disposable cryosurgical instrument |
DE2513868C2 (en) | 1974-04-01 | 1982-11-04 | Olympus Optical Co., Ltd., Tokyo | Bipolar electrodiathermy forceps |
US4196724A (en) | 1978-01-31 | 1980-04-08 | Frecker William H | Tongue locking device |
DE3050386C2 (en) | 1980-05-13 | 1987-06-25 | American Hospital Supply Corp | Multipolar electrosurgical device |
JPS5755573A (en) | 1980-09-18 | 1982-04-02 | Olympus Optical Co Ltd | Cassette storing device |
US4565200A (en) | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
US4411266A (en) | 1980-09-24 | 1983-10-25 | Cosman Eric R | Thermocouple radio frequency lesion electrode |
US5435805A (en) | 1992-08-12 | 1995-07-25 | Vidamed, Inc. | Medical probe device with optical viewing capability |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5385544A (en) | 1992-08-12 | 1995-01-31 | Vidamed, Inc. | BPH ablation method and apparatus |
US5421819A (en) | 1992-08-12 | 1995-06-06 | Vidamed, Inc. | Medical probe device |
US4705041A (en) | 1984-07-06 | 1987-11-10 | Kim Il G | Dilator for Sphincter of Oddi |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US5365926A (en) | 1986-11-14 | 1994-11-22 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US4901737A (en) | 1987-04-13 | 1990-02-20 | Toone Kent J | Method and therapeutic apparatus for reducing snoring |
US4943290A (en) | 1987-06-23 | 1990-07-24 | Concept Inc. | Electrolyte purging electrode tip |
JPS6446056U (en) | 1987-09-17 | 1989-03-22 | ||
US4907589A (en) | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
DE3821544C2 (en) | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
US4947842A (en) | 1988-09-22 | 1990-08-14 | Medical Engineering And Development Institute, Inc. | Method and apparatus for treating tissue with first and second modalities |
US4906203A (en) | 1988-10-24 | 1990-03-06 | General Motors Corporation | Electrical connector with shorting clip |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US4966597A (en) | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
CA1332905C (en) | 1989-03-10 | 1994-11-08 | John A. Murchie | Method and apparatus for treatment of snoring |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5078717A (en) | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5125928A (en) | 1989-04-13 | 1992-06-30 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5057107A (en) | 1989-04-13 | 1991-10-15 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
DE3915636C1 (en) | 1989-05-12 | 1990-04-26 | Sass, Wolfgang, Dr. | |
US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
US5035696A (en) | 1990-02-02 | 1991-07-30 | Everest Medical Corporation | Electrosurgical instrument for conducting endoscopic retrograde sphincterotomy |
US5205287A (en) | 1990-04-26 | 1993-04-27 | Hoechst Aktiengesellschaft | Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
US5122137A (en) | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5190540A (en) | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
US5083565A (en) | 1990-08-03 | 1992-01-28 | Everest Medical Corporation | Electrosurgical instrument for ablating endocardial tissue |
US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
EP0503019B1 (en) | 1990-10-03 | 1996-03-27 | TRUFFER, Ernest | Snoring prevention device |
US5256138A (en) | 1990-10-04 | 1993-10-26 | The Birtcher Corporation | Electrosurgical handpiece incorporating blade and conductive gas functionality |
US5088979A (en) | 1990-10-11 | 1992-02-18 | Wilson-Cook Medical Inc. | Method for esophageal invagination and devices useful therein |
US5190541A (en) | 1990-10-17 | 1993-03-02 | Boston Scientific Corporation | Surgical instrument and method |
US5094233A (en) | 1991-01-11 | 1992-03-10 | Brennan Louis G | Turbinate sheath device |
US5368557A (en) | 1991-01-11 | 1994-11-29 | Baxter International Inc. | Ultrasonic ablation catheter device having multiple ultrasound transmission members |
US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
US5156151A (en) | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5275610A (en) | 1991-05-13 | 1994-01-04 | Cook Incorporated | Surgical retractors and method of use |
JPH06507797A (en) | 1991-05-24 | 1994-09-08 | イーピー・テクノロジーズ・インコーポレーテッド | Single-phase action potential/ablation combination catheter and high-performance filter system |
US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5275608A (en) | 1991-10-16 | 1994-01-04 | Implemed, Inc. | Generic endoscopic instrument |
CA2106409A1 (en) | 1991-11-08 | 1993-05-09 | Stuart D. Edwards | Radiofrequency ablation with phase sensitive power detection |
US5275162A (en) | 1991-11-08 | 1994-01-04 | Ep Technologies, Inc. | Valve mapping catheter |
US5328467A (en) | 1991-11-08 | 1994-07-12 | Ep Technologies, Inc. | Catheter having a torque transmitting sleeve |
ATE241938T1 (en) | 1991-11-08 | 2003-06-15 | Boston Scient Ltd | ABLATION ELECTRODE WITH INSULATED TEMPERATURE MEASUREMENT ELEMENT |
US5363861A (en) | 1991-11-08 | 1994-11-15 | Ep Technologies, Inc. | Electrode tip assembly with variable resistance to bending |
US5257451A (en) | 1991-11-08 | 1993-11-02 | Ep Technologies, Inc. | Method of making durable sleeve for enclosing a bendable electrode tip assembly |
US5197964A (en) | 1991-11-12 | 1993-03-30 | Everest Medical Corporation | Bipolar instrument utilizing one stationary electrode and one movable electrode |
US5197963A (en) | 1991-12-02 | 1993-03-30 | Everest Medical Corporation | Electrosurgical instrument with extendable sheath for irrigation and aspiration |
US5242441A (en) | 1992-02-24 | 1993-09-07 | Boaz Avitall | Deflectable catheter with rotatable tip electrode |
US5263493A (en) * | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5281216A (en) | 1992-03-31 | 1994-01-25 | Valleylab, Inc. | Electrosurgical bipolar treating apparatus |
WO1993020768A1 (en) | 1992-04-13 | 1993-10-28 | Ep Technologies, Inc. | Steerable microwave antenna systems for cardiac ablation |
US5314466A (en) | 1992-04-13 | 1994-05-24 | Ep Technologies, Inc. | Articulated unidirectional microwave antenna systems for cardiac ablation |
WO1993020886A1 (en) | 1992-04-13 | 1993-10-28 | Ep Technologies, Inc. | Articulated systems for cardiac ablation |
US5281217A (en) | 1992-04-13 | 1994-01-25 | Ep Technologies, Inc. | Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns |
US5277201A (en) | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5254126A (en) | 1992-06-24 | 1993-10-19 | Ethicon, Inc. | Endoscopic suture punch |
US5456662A (en) | 1993-02-02 | 1995-10-10 | Edwards; Stuart D. | Method for reducing snoring by RF ablation of the uvula |
US5470308A (en) | 1992-08-12 | 1995-11-28 | Vidamed, Inc. | Medical probe with biopsy stylet |
US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5401272A (en) | 1992-09-25 | 1995-03-28 | Envision Surgical Systems, Inc. | Multimodality probe with extendable bipolar electrodes |
US5309910A (en) | 1992-09-25 | 1994-05-10 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
US5471982A (en) | 1992-09-29 | 1995-12-05 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US5334196A (en) | 1992-10-05 | 1994-08-02 | United States Surgical Corporation | Endoscopic fastener remover |
US5415657A (en) | 1992-10-13 | 1995-05-16 | Taymor-Luria; Howard | Percutaneous vascular sealing method |
AU5456494A (en) | 1992-11-13 | 1994-06-08 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical probe |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5409483A (en) | 1993-01-22 | 1995-04-25 | Jeffrey H. Reese | Direct visualization surgical probe |
US5336222A (en) | 1993-03-29 | 1994-08-09 | Boston Scientific Corporation | Integrated catheter for diverse in situ tissue therapy |
US5403311A (en) | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5365945A (en) | 1993-04-13 | 1994-11-22 | Halstrom Leonard W | Adjustable dental applicance for treatment of snoring and obstructive sleep apnea |
US5860974A (en) * | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
DE4323585A1 (en) | 1993-07-14 | 1995-01-19 | Delma Elektro Med App | Bipolar high-frequency surgical instrument |
US5797903A (en) * | 1996-04-12 | 1998-08-25 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces |
US5433739A (en) | 1993-11-02 | 1995-07-18 | Sluijter; Menno E. | Method and apparatus for heating an intervertebral disc for relief of back pain |
US5472441A (en) | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5458597A (en) | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5423812A (en) | 1994-01-31 | 1995-06-13 | Ellman; Alan G. | Electrosurgical stripping electrode for palatopharynx tissue |
US5448990A (en) | 1994-02-15 | 1995-09-12 | Very Inventive Physicians, Inc. | Endoscope viewing cannula and surgical techniques |
US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US6056744A (en) * | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5823197A (en) * | 1994-06-24 | 1998-10-20 | Somnus Medical Technologies, Inc. | Method for internal ablation of turbinates |
US5454782A (en) * | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
US5571116A (en) | 1994-10-02 | 1996-11-05 | United States Surgical Corporation | Non-invasive treatment of gastroesophageal reflux disease |
US5836874A (en) * | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
AU3204097A (en) * | 1996-05-22 | 1997-12-09 | Somnus Medical Technologies, Inc. | Method and apparatus for ablating turbinates |
US6073052A (en) * | 1996-11-15 | 2000-06-06 | Zelickson; Brian D. | Device and method for treatment of gastroesophageal reflux disease |
US6273907B1 (en) * | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
-
1999
- 1999-01-13 CA CA002318315A patent/CA2318315A1/en not_active Abandoned
- 1999-01-13 WO PCT/US1999/000693 patent/WO1999035986A1/en not_active Application Discontinuation
- 1999-01-13 AU AU22244/99A patent/AU2224499A/en not_active Abandoned
- 1999-01-13 EP EP99902209A patent/EP1047348A1/en not_active Withdrawn
- 1999-01-13 JP JP2000539768A patent/JP2002508989A/en active Pending
-
2001
- 2001-07-24 US US09/911,874 patent/US20020115991A1/en not_active Abandoned
-
2004
- 2004-11-12 US US10/986,687 patent/US7462179B2/en not_active Expired - Fee Related
-
2008
- 2008-12-03 US US12/315,423 patent/US20090131928A1/en not_active Abandoned
-
2011
- 2011-12-15 US US13/327,105 patent/US20120089138A1/en not_active Abandoned
-
2013
- 2013-08-03 US US13/958,542 patent/US20130317497A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197022B1 (en) * | 1996-07-30 | 2001-03-06 | James A. Baker | Medical instruments and techniques for treatment of gastro-esophageal reflux disease |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10953170B2 (en) | 2003-05-13 | 2021-03-23 | Nuvaira, Inc. | Apparatus for treating asthma using neurotoxin |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US9125643B2 (en) | 2008-02-15 | 2015-09-08 | Holaira, Inc. | System and method for bronchial dilation |
US8731672B2 (en) | 2008-02-15 | 2014-05-20 | Holaira, Inc. | System and method for bronchial dilation |
US11058879B2 (en) | 2008-02-15 | 2021-07-13 | Nuvaira, Inc. | System and method for bronchial dilation |
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US10149714B2 (en) | 2008-05-09 | 2018-12-11 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8961507B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8961508B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US9668809B2 (en) | 2008-05-09 | 2017-06-06 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8821489B2 (en) | 2008-05-09 | 2014-09-02 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US11937868B2 (en) | 2008-05-09 | 2024-03-26 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9017324B2 (en) | 2009-10-27 | 2015-04-28 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8777943B2 (en) | 2009-10-27 | 2014-07-15 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9649153B2 (en) | 2009-10-27 | 2017-05-16 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8932289B2 (en) | 2009-10-27 | 2015-01-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9005195B2 (en) | 2009-10-27 | 2015-04-14 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9675412B2 (en) | 2009-10-27 | 2017-06-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9931162B2 (en) | 2009-10-27 | 2018-04-03 | Nuvaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9649154B2 (en) | 2009-11-11 | 2017-05-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US10610283B2 (en) | 2009-11-11 | 2020-04-07 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US11389233B2 (en) | 2009-11-11 | 2022-07-19 | Nuvaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US11712283B2 (en) | 2009-11-11 | 2023-08-01 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
Also Published As
Publication number | Publication date |
---|---|
US7462179B2 (en) | 2008-12-09 |
CA2318315A1 (en) | 1999-07-22 |
US20060009758A1 (en) | 2006-01-12 |
US20020115991A1 (en) | 2002-08-22 |
US20090131928A1 (en) | 2009-05-21 |
WO1999035986A1 (en) | 1999-07-22 |
JP2002508989A (en) | 2002-03-26 |
AU2224499A (en) | 1999-08-02 |
US20130317497A1 (en) | 2013-11-28 |
EP1047348A1 (en) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7462179B2 (en) | GERD treatment apparatus and method | |
US8313484B2 (en) | GERD treatment apparatus and method | |
US6846312B2 (en) | GERD treatment apparatus and method | |
EP1056403B1 (en) | Electrosurgical sphincter treatment apparatus | |
US6092528A (en) | Method to treat esophageal sphincters | |
US8454595B2 (en) | Sphincter treatment apparatus | |
US6749607B2 (en) | Apparatus to treat esophageal sphincters | |
US6712814B2 (en) | Method for treating a sphincter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |